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ABSTRACT 
In this dissertation, spectroscopy has been used to solve a variety of problems in different 
domains of science.  Therefore, each chapter consists of different examples that have been 
addressed using different concepts of spectroscopy.  
The objective of part I (application of solution state NMR spectroscopy in pharmaceutical 
sciences) is to apply NMR techniques in different pharmaceutical projects. In chapter3, a real-time 
quantification of in vitro Bortezomib (BTZ) release from alginate microparticles using a solution-
state quantitative boron nuclear magnetic resonance (11B qNMR) method is presented. The method 
was validated according to International Conference on Harmonization (ICH) guidelines. 
Therefore, several analytical performance parameters were discussed such as limit of detection 
(LOD), limit of quantification (LOQ), linearity, specificity, accuracy, precision and robustness.    
The 11B qNMR method was applied to the in vitro release study of a model drug, bortezomib 
(BTZ) from alginate microparticles and results were compared to a commonly used dialysis 
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method. Throughout the release study, the dialysis method consistently underestimated the level 
of drug released, probably due to the separating membrane that can interfere with the real-time 
drug transport process. Overall, compared to the dialysis method, the direct 11B qNMR method 
was accurate and provided a direct and real-time quantification of BTZ for an effective study of 
drug release kinetics.  
Similarly, in chapter 4, a 19F qNMR method was developed and validated and then applied 
to study the real-time release of maraviroc from a microparticle formulation in a vaginal and 
seminal stimulated environment. Different possibilities were discussed to control the release 
profile such as the crosslinking process and a pH sensitive polymer.  
In chapter 5, the project is a collaborative effort between the department of Chemistry and 
School of Pharmacy. Our contributions in that project are to utilize 11B NMR spectroscopy 
technique as a characterization tool for the reaction progression. Moreover, to perform theoretical 
and experimental calculations and compare them to each other in order to trace the reaction 
mechanism. The overall motivation of the project is to test an assumption about phenylboronic 
acid (PBA) to prevent HIV transmission. It has been found that phenylboronic acid can form 
boronic acid in the presence of cis-diol, like the one found in HIV-gp120 glycoproteins. In order 
to exam the proposed hypothesis, a derivative of phenylboronic acid was synthesized. The 
synthetic scheme and the spectroscopic results are presented and discussed in detail.  
 The objective of part II (applications of solid-state NMR spectroscopy) is to apply SSNMR 
spectroscopy experiments in two projects to gain significant information about specific materials. 
In chapter 6, some main concepts of SSNMR spectroscopy are discussed as well as some basic 
SSNMR experiments. 
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 In chapter 7, boron carbide thin films were grown using plasma enhanced chemical vapor 
deposition (PECVD) under different growth conditions. Different possible spectroscopic 
techniques were discussed in order to discover the local physical structure of boron carbide thin 
films. However, most of these techniques have shown a lack of an ability to demonstrate the 
internal structure of thin films. SSNMR spectroscopy was successfully employed to reveal 
information about the internal structure of boron carbide thin films.  
In chapter 8, the optical properties of titanium oxide TiO2 were modified by introducing a 
hydrazine molecule. SSNMR spectroscopy was implemented to monitor the reaction progression 
of TiO2 to improve its optical properties.   
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1.1 Overview 
Spectroscopy is a very broad field which studies the interaction between matter and energy. 
It is divided into various subfields based on the nature of interaction as well as the type of material. 
When matter is exposed to electromagnetic radiation, different types of interactions may occur 
including absorption, emission, reflection, elastic scattering, and inelastic scattering1. All these 
interactions can happen to different components of a molecule. For instance, electronic excitation 
(UV) occurs in between electron orbitals, molecular vibrations (IR) takes place in the molecule, 
and nuclear spin transitions (NMR) occur in the nucleus. Despite the difference of interactions, all 
spectroscopic techniques measure the change in intensity and/or frequency of the energy of the 
interaction.  The interpretation of those interactions reveal fundamental information about physical 
structure. Spectroscopy is used daily in chemistry as it can accurately probe information about 
atomic and molecular properties. Understanding the physical structure of a molecule is an essential 
step in analytical chemistry. Various types of spectroscopic techniques can be applied to achieve 
this goal like Solution State and Solid State nuclear magnetic resonance (NMR) spectroscopy, 
Infrared (IR) spectroscopy, Ultraviolet/ visible (UV/Vis), Atomic absorption (AA), atomic 
emission (AE).  In this dissertation, I have mainly utilized solution state and solid state NMR as 
well as IR to obtain quantitative, qualitative, and theoretical analyses of different molecular species 
in different contexts.  
1.2 NMR 
In 1938, Nuclear Magnetic Resonance Spectroscopy was discovered by Isidor Rabi who 
was awarded the Nobel prize in physics 19442. NMR phenomena is very suitable technique to 
examine the chemical, physical and biological properties of matter. NMR is powerful and widely 
used analytical tool in chemistry, biology, pharmacy and geology. It is a non- destructive technique 
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that has greatly contributed to compound identification.  For modern studies, NMR turns out to be 
an indispensable technique as it can give a multitude of information about molecular structure 
including configuration, concentration, and intermolecular interaction at the atomic level. 
Nowadays, chemists are able to obtain 2- and 3- dimensional NMR spectra by a few clicks of a 
button. Although NMR has been utilized routinely, care must be taken when setting NMR 
experimental parameters. Incorrect setup may convert the spectra from a beneficial to a 
meaningless result. Furthermore, this could lead to damaging the equipment, which will cost 
thousands of dollars to repair. Hence, understanding the basic concepts of NMR can ensure the 
best results.  
  In order to understand NMR phenomena, it is important to have a closer look at molecular 
structures, which are usually the target matter examined by NMR. A molecule is composed of 
atoms, which are made of electrons and nuclei. Under the electron cloud of an atom lies the nucleus 
with its neutrons and protons. The proton, neutron, and electron possess a property called a spin, 
which acts as a small magnetic dipole. Hence, NMR phenomena relies on intrinsic spin properties 
of nuclei. Spin can be expressed using the quantum number (I). In order for any given nucleus to 
be NMR active, it has to have a non-zero net spin, which occurs when we have unpaired protons 
and/or neutrons (Table1-1). 
       In the absence of an external magnetic field (B0), each magnet orients randomly. When 
external magnetic fields are applied, all magnets are aligned and precess around the magnetic field.  
For isotopes with spin =1/2 such 1H and 13C, there are 2I+1=2 possible orientations which can be 
distinguished by quantum number m (m= +1/2 or -1/2). In the absence of external magnetic fields, 
all nuclei are oriented randomly because of thermal effects and spin vectors that orient everywhere 
leaving zero net magnetization. When an external magnetic field is applied, nuclei with non-zero 
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spin angular momentum orient either aligned or opposite with the external magnetic field as shown 
in (Figure1-1)3. For nuclei with a positive gyromagnetic ratio γ, the parallel orientation which has 
lower energy (α spin state or +1/2) is preferred more than the antiparallel orientation which has 
higher energy (β spin state or -1/2). At equilibrium, the population of the alpha state is slightly 
higher than the beta energy state. This interaction between external magnetic fields and nuclear 
magnetic moment is known as a Zeeman splitting (Figure1-2)3. Mathematically, we can calculate 
the population difference using Boltzman distribution (N-/N+ = e-E/kT  where k is Boltzman’s 
constant 1.3805x10-23 JK-1)4. The population difference leads to a net magnetization (Mo) vector 
in Z+ direction. This net magnetization is precessing around B0, and this precession is known as 
Lamor precession Equation(1-1) (Figure1-3)3 where B0 is the magnetic field and γ is the 
gyromagnetic ratio.  The Lamor frequency is proportional to the magnetic field. 
                     ω0=-γ B0                                               (1-1) 
      When electric current is applied through a wire coil, it will generate a magnetic field (B1) 
inside the coil. NMR is performed with two magnetic fields, one large Zeeman field and another 
much smaller field used to perturb the net magnetization. As shown in (Figure1-4)3 the second 
magnetic field is oriented perpendicular to the B0. If the current of the electrical wire which is used 
to generate the second magnetic field B1 oscillates at the same frequency of Lamor frequency ω0, 
the energy will be absorbed and the population of α and β are perturbed. Under these 
circumstances, the net magnetization (M0) is tipped into the xy plane precessing around B1 
simultaneously with its precession around B0. The application of B1 will be briefly applied for ≤ 
seconds and is known as a radio frequency RF pulse.  When B1 is turned off, the net magnetization 
relaxes back to equilibrium along the Z-direction (Figure1-5)3. During the relaxation process, a 
current profile of the current developed in the coil by the precessing net magnetizations is recorded. 
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This profile is identified as the free induction decay (FID). Since the FID is in a time domain, a 
mathematical technique called Fourier transform (FT) will be performed to convert the FID from 
time domain to frequency domain (Figure1-6)3. 
      Nuclei with a quantum spin number higher than 1/2 are called quadrupolar nuclei. In the 
application of an external magnetic field, the energy splits into multiple levels (Figure 1-7)5. Boron 
has a 3/2 spin number. Therefore, it will split into five different energy levels. More about 
quadrupolar nuclei will be discussed later.  
      An NMR spectrum is a plot of absorption against frequency. For any given nuclei with spin 
1/2, the NMR spectrum ideally should look like the spectrum in (Figure1-8)6. Several parameters 
can be extracted from the spectrum such as central frequency, area, and line-width. The central 
frequency is related to the chemical shift, which is the position of the peak shown in ppm value. 
The chemical shift is very important as it reveals information about the local environment. The 
area is related to the number of spins, which is the number of nuclei present at that shift.  Line-
width has number of components, including some orientation dependence. 
1.3 Relaxation 
The two fundamental types of relaxation in NMR include spin-lattice relaxation or 
longitudinal relaxation (T1) and spin-spin or transverse relaxation (T2). These phenomena 
describe how the signal changes with time. Understanding the concept of relaxation is important 
for an appropriate NMR spectrum measurement and interpretation 7–9.  
      When there is no external magnetic field applied, the total magnetic polarization is zero for 
any given active nuclei. Nonetheless, when the external magnetic field is suddenly applied, the 
total magnetic moment is initially zero and it will gradually grow until reaching thermal 
equilibrium. The loss and gain of the net magnetization around z-axis is known as a Spin-lattice 
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relaxation or longitudinal relaxation with a time constant T1. The term ‘lattice’ formerly used in 
the early days of NMR when they used the interaction of nuclear spins and crystal lattice to explain 
the thermal equilibrium. Conversely, the term ‘longitudinal’ is used to indicate that the 
magnetization build up is in the same direction as the applied magnetic field B0. The term 
‘relaxation’ is commonly used, especially in physics, with a particular meaning indicating the re-
establishment of thermal equilibrium after applying some perturbation. Equation (1-2) governs 
this process as a function of time. In the absence of the magnetic field, the equilibrium is 
established, and then broken after applying an external magnetic field. The longitudinal spin 
magnetization builds up and establishes a new equilibrium state (Figure1-9)10. The spin-lattice 
relaxation time constant T1 depends on the sample and some of its parameters such as temperature 
and viscosity (if the sample is in solution state). For most samples, the relaxation time constant 
can range from milliseconds to seconds; however, there are a few materials in which T1 can span 
hours or days 4.   
 
                    Mz = M0 (1-e
-t/T1)                                 (1-2) 
Where: Mz  longitudinal magnetization 
            M0  magnetization at the equilibrium 
           t time 
           T1 spin-longitudinal relaxation time constant 
       In the presence of the large external magnetic field B0 , the longitudinal spin magnetization 
is too small to be detected. It is four times smaller than the normal diamagnetism of the sample in 
magnitude. Hence, NMR spectroscopy follows a different methodology, which involves 
6 
 
perturbing the magnetization and then measuring the perpendicular magnetization instead of 
measuring the net magnetization along the external magnetic field.  
  If a radio frequency pulse is applied (r.f pulse π/2), the magnetization will rotate from z-
axis to –y-axis. Therefore, all the net spin polarization will transfer from z-axis to –y-axis, where 
it will be perpendicular to the magnetic field (Figure1-10). This perpendicular magnetic moment 
is known as a transverse magnetization. When the r.f pulse is suddenly turned off, the transverse 
magnetic moment around –y-axis will gradually decay and simultaneously start precessing around 
the z-axis. The time it takes the transverse magnetic moment to decay is called spin-spin relaxation 
or transverse relaxation time constant T2, and it can be described using Equation (1-3).  
            Mxy= Mxyo e
-t/T2                                               (1-3) 
Where : Mxy transverse magnetization 
             Mxyo transverse magnetization at equilibrium 
            t time, T2  transverse relaxation time constant 
       In theory, T2 can be measured by applying a specific pulse to create a transverse 
magnetization and then measure the decoherence constant of the FID. However, in fact there are 
several parameters, which dramatically influence the rate of the decay such as magnetic field 
inhomogeneity, sample inhomogeneity, and anything that perturbs the internal motion like 
temperature and humidity. As a result of these effects, the decoherence constant of the FID is 
called T2
* rather than T2.  Generally, T2 is greater than or equal to T2
*. Moreover, T2 is an 
instrumentally independent parameter while the T2
* is not. According to Equation (1-4), T2
* 
governs the apparent line width of the NMR spectrum.  
 There are different factors that can be the main sources of broadening NMR lines. Some 
of them are related to instrumental problems such as tuning and shimming while others are related 
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to sample problems such as sample inhomogeneity (poor mixing) and temperature gradients 
around the sample. However, the source of NMR line broadening topic would be incomplete 
without mentioning motion based relaxation.  Internal motion can play a significant role in both 
the intensity and width of the NMR peak.    
      The spin-lattice relaxation mechanism depends on the rate of molecular motion; this 
motion is related to the correlation time, which is the time it takes a spherical molecule to rotate 
by one radian. The spin-lattice relaxation (T1) will be large when we have a molecule with a very 
small correlation time, which also indicates a rapid molecular motion as shown in (Figure 1-11)11. 
Moreover, T1 is also large when we have a solid sample since the molecular motion is hindered 
and the correlation time is too long. Under these circumstances, the intensity will not be as strong 
at that frequency as it would be. Interaction with unpaired electrons such as paramagnetic 
substances can lead to a fruitless line broadening in NMR. Lastly, in quadrupolar nuclei (I> ½) 
there will be an interaction with the electric field gradient which typically results in very short 
relaxation time and, thus, broaden the NMR lines.   
      There is a notable relationship between T1 relaxation and the chemical structure. When 
comparing the T1 value for two different carbon ,quaternary carbon and carbon bonded directly to 
a proton, we will find that the T1 value for the quaternary carbon can vary from 10-300s. On the 
other hand, the T1 value of a carbon bonded directly to a proton only ranges from 0.1-10s. This is 
because of the 1H-13C dipole-dipole interaction, which has a direct effect on T1. Typically, the 
more hydrogen atoms attached to 13C, the smaller T1 value will be.  
      NMR signal reduction derived from incorrectly estimating the value of T1 can be avoided 
by setting up the spin-lattice relaxation time constant accurately. The most common experiment to 
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measure T1 is the inversion recovery experiment. Figure1-1211 shows the pulse sequence of the 
inversion recovery experiment. More details about T1 measurements will be discussed later.  
      Not only does T1 have a critical effect on broadening NMR signal, but T2 (spin-spin 
relaxation) also has a significant effect too. According to the Equation (1-4), the linewidth of the 
NMR signal is directly dependent on T2. The size of molecule, viscosity and hydrophobicity tend 
to vary the T2
 value remarkably12,13. When molecular weight increases, the correlation time 
increases too. Therefore, T2
 decreases and the line width of NMR peak increases.  
      Large molecules such as a polymers and proteins have a tendency to possess a very slow 
molecular tumbling and a long correlation time. Therefore, these large molecules have relatively 
small T2
 values (Figure1-11) which will result in a very broad NMR signal Equation (1-4). We 
took advantage of the T2 molecular size dependent and studied a real-time quantification of boron 
and fluorine containing drugs’ release from nano/microparticles formulations. When the drug is 
free in the solution, we can see a clear 11B or 19F NMR peak with a narrow line. However, when 
the drug is encapsulated inside the polymer, it has a very fast T2 and, thus, a very broad and noisy 
NMR signal is not observed. 
      In solution-state NMR, the viscosity of the solvent plays a substantial role in T2 value since 
different measurements give different T2 values.  As shown in (Figure1-11), as the viscosity 
increases, the T2 gets smaller. Consequently, the NMR peak will be more broad and noisy14,15. 
Additionally, interactions between solvent and solute have a key influence on T2. It has been found 
that the polar or hydrophobic environment samples can drive clustering which eventually will 
cause of broadening the signal16. More about this topic will be covered later.  
               Line width= (1/T*2)
-1                      (1-4) 
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1.4 Interactions in NMR 
Generally, there are internal and external interactions in NMR for any given nucleus as 
shown in Equation (1-5). Table 1-2 and (Figures1-13,14) 17show the relative magnitude of these 
interactions and how these interactions can cause a small perturbation of the resonance from the 
lamor frequency. The Zeeman and quadrupolar interactions are the largest, on the order of 100MHz 
and 1-5MHz respectively, followed by dipolar and chemical shift interactions which are on order 
of 1-5KHz. The smallest interaction is related to J-coupling interaction, which is only <102 Hz 18. 
                 ĤN= ĤZ + ĤQ + ĤDD + Ĥcs + ĤJ                                      (1-5) 
 
Where:  ĤZ is the Zeeman interaction 
ĤQ is the quadrupolar interaction 
ĤDD is the dipolar interaction 
Ĥcs is the chemical shift 
ĤJ is the J-coupling 
1.4.1 Zeeman interaction 
 The Zeeman interaction is an external interaction, which occurs between the spin magnetic 
moment and magnetic field B0.  
1.4.2 Chemical shift 
 The chemical shift δ is the resonance frequency of a nucleus relative to a standard in a 
magnetic field. Typically, it is expressed in parts per million (ppm). Chemical shifts provide 
essential information about the structure of the molecule and assist in compound identification. 
Moreover, chemical shifts play a supporting role in distinguishing which nucleus belongs to which 
functional group. Chemical shift is an anisotropic parameter, which means it is directionally 
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dependent.  The magnitude of the chemical shift depends on the orientation of the molecule relative 
to the applied magnetic field. Hence, chemical shift is a three dimensional property.  In solution 
NMR, the molecules randomly tumble, and their motions are significantly faster than the actual 
NMR experiment. Therefore, the obtained chemical shift is the average chemical shifts of all 
molecular orientations, and it is known as the isotropic chemical shift (Figure1-15).  
 On the other hand, in solid- state NMR, the situation is entirely different. The orientation 
of the solid sample is restricted. For example, an amorphous solid sample can be approximated as 
composed of lots of single crystals oriented in all directions with respect to the applied magnetic 
field. Under these circumstances, different chemical shifts will be observed which will cause a 
substantial broadening in the peak because of the different orientations. The shape of the peak, 
known as a powder spectrum, is shown in (Figure1-16)19. Unlike amorphous solid, in a single 
crystal (crystalline solid) all molecules have the same orientation with respect to the magnetic 
field. Hence, a narrow peak is going to be observed. If the single crystal changes its orientation, 
the peak is going to move to a different chemical shift as shown in (Figure1-17).    
1.4.3 Dipolar interaction 
 The dipolar interaction is a direct interaction between nuclear spins through space. It is 
classified to homonuclear and heteronuclear coupling. In homonuclear coupling, the interaction 
happens between identical nuclear isotopes while in heteronuclear coupling the interaction 
happens between different nuclear isotopes.   
 A nucleus with spin ½ possesses a dipole moment, so it will be oriented either parallel or 
anti-parallel to the static magnetic field, and these two spin states have almost equal energy. 
Frequently, the interesting nuclei is not in an isolated system, which means that nucleus is 
surrounded by another nuclei. These nuclei also have multiple spin states. The target nucleus will 
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be influenced by the spin states of the neighboring nucleus via dipolar and J coupling. 
Consequently, the line in the NMR spectrum is going to be split into a multiplet. 
 A nucleus with spin higher than ½ possesses a quadrupole moment and it will have more 
than two spin states. When the interested nucleus is influenced by another nucleus, the line in NMR 
spectrum is going to split to a different multiplet.  
1.4.4 J-coupling  
 In contrast to dipolar coupling, J-coupling is an indirect interaction of nuclear spins 
mediated by the electrons in the molecule. Typically, the anisotropic part of the interaction is very 
small and can be neglected, so only the isotropic value is relevant.   
 In SSNMR spectroscopy, J-coupling is indeed hard to measure because of the resolution 
problems. Hence, J-coupling is not as important in SSNMR spectroscopy as in solution state NMR 
spectroscopy where it provides valuable information about connectivity through bonds. 
1.4.5 Quadrupolar interaction 
The quadrupolar interaction is a crucial topic in both solid and solution NMR spectroscopy. 
It is defined as an electric coupling between the nuclear quadrupole moment Q and local electric 
field gradient. Nuclei with spin I=1/2 have a spherical positive charge distribution in contrast to 
quadrupolar nuclei with spin I>1/2. It has an asymmetric distribution around the nucleus, which 
will give a rise to a non-spherical positive charge distribution. The asymmetric positive charge 
distribution can be described by the nuclear electric quadrupole moment (eQ), which is an intrinsic 
property of the nucleus. The quadrupole nucleus interacts with an applied magnetic field while the 
electric quadrupole moment interacts with the electric field gradient (EFG). The strength of this 
interaction depends upon two main factors:  the magnitude of electric quadrupole moment (eQ) as 
well as the strength of electric field gradient (EFG). Mostly, the electric quadrupole moment 
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expresses as eQ, where e is the positive charge of a proton, and it has a constant value for any 
given quadrupole nuclear regardless of the change in the electric field gradient.  
      When the strength of the zeeman interaction (applied magnetic field B0 ) with the nucleus 
is on the similar order of magnitude to the strength of quadruple interaction, then the applied field 
will not be considered as the quantization axis any more leading to 2nd order perturbation effects. 
The interaction will be anisotropic, so it depends on the orientation with respect to the magnetic 
field. In order for the zeeman and quadrupole interactions to be comparable, they do not have to 
be identical in scale, for instance, for 11B the zeeman is around 115 MHz while a big quadruple 
interaction is around 5 MHz, ( less than 5%), the second order effects are still present.  
1.5 Averaging of NMR interactions 
 In solution state NMR spectroscopy, molecular motion is freely random, hence all 
anisotropic interaction will average to zero. However, in SSNMR spectroscopy the molecular 
motion is absent or severely restricted. Consequently, all these interactions are going to lead to a 
very poor spectrum with a broad line and lower resolution, which makes the identification and the 
analysis of the spectrum featureless as shown in (Figure1-18 ) 17. In order to enhance the 
spectrum’s quality and resolution, the sample must be spun at the magic angle with respect to the 
applied magnetic field. More about the magic angle spinning technique will be covered later in 
chapter 6.    
  1.6 Solution NMR vs. SSNMR spectroscopy   
  As a tool of analysis, solution state NMR is well established and has evolved rapidly.  
Generally, when NMR is mentioned it refers to solution state NMR spectroscopy. The structural 
information is acquired based on the isotropic interactions like isotropic chemical shift and J 
coupling, as well as relaxation information. In order for this type of experiment to be applicable, 
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the sample has to be in a solution phase for testing. Unlike SSNMR, solution state NMR has better 
resolution, narrow linewidths, and strong signal intensity due to the rapid isotropic orientation and 
apparent lack of anisotropic interactions20. However, the target sample has to be soluble in 
deuterated solvents to acquire proton solution NMR spectrum.  
      In contrast to well-known solution state NMR, the structural information that we gain from 
SSNMR is based on chemical shift anisotropy (CSA) and dipolar coupling, regardless of the 
solubility and crystallinity of the sample. Typically, SSNMR spectrum has broader linewidths and 
has lower resolution compared to the solution NMR spectrum. There are three important reasons 
that make the SSNMR spectrum less readily useful. First is the dipolar broadening which is the 
interaction between two spins. Second is the chemical shift anisotropy (CSA) which arises from 
the asymmetry of electronic density around the nuclei. Third is the quadrupolar interactions. In the 
solution NMR spectroscopy, all these factors average to zero due to the fast isotropic motion of 
the sample. Luckily, we can mostly average all these factors to zero and acquire high-resolution 
spectra with narrow lines, ~0.1Hz for solution and 1-100 Hz solid state NMR respectively, by 
applying different strategies such as magic angle spinning (MAS)21,22 and cross polarization 
(CP)23,24 since all of the factors are orientation dependent. More explanation about these strategies 
will be discussed later.   
 In order to identify the structural information of any given sample, a high abundance of 
these nuclei is required to make this technique sensitive, and give high signal-to-noise (S/N) 
SSNMR spectra. Unfortunately, not all nuclei have high abundance, specifically 13C which makes 
up only 1% of all natural carbon on earth. Consequently, NMR spectroscopy is going to be 
significantly less sensitive to those nuclei and our analysis will be hampered by a low signal-to-
noise ratio due to the low natural abundance. Moreover, since there are spin-spin heteronuclear 
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interactions, we can implement heteronuclear correlation experiments between different nuclei 
based on the S/N. It is essentially impossible to determine homonuclear correlations for certain 
specific nuclei in a natural abundance sample such as 13C. If a correlation experiment is performed 
to measure 13C-13C distance, the probability of a neighboring 13C is only 1%, and the maximum 
peak height that can be gained is going to be only 1%. Therefore, using isotopic labeling schemes 
will have major impacts such as an improvement in S/N by a factor of ~90 fold in homonuclear 
correlations experiments. Another impact is the ability to measure interatomic distances by doing 
correlation experiments and 2D experiments 25.  
  In contrast to solution state NMR, SSNMR sample preparation and handling are difficult. 
Packing and unpacking the sample in a very small rotor is more complicated than ejecting the 
sample in NMR tube for solution NMR. Additionally, to use it properly, SSNMR requires more 
expertise 5,26.  
  1.7 NMR components 
      Generally, NMR spectrometer contains several parts:  the magnet, the shim coils, the 
probe, the transmitter, the receiver and the computer.  Figure 1-1927 shows a schematic 
representation for NMR components 27,28.  
      The NMR magnet is the most essential part of NMR hardware as well as the most expensive 
one. Most NMR experiments require a homogenous magnetic field along with a highly stable 
magnetic field. These requirements are necessary to acquire a spectrum with better resolution and 
avoid a broad NMR signal. The magnet in early NMR spectrometer systems was iron core 
permanent or electromagnetic and it generated only a 1.5 T magnetic field. However, the type of 
magnet has evolved substantially. Recently, most NMR spectrometers have superconducting 
magnets, which have a strength field from 6 to 23.5 T. The superconducting magnet wires are 
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made of (NbTaTi)3Sn, and embedded with copper because this material is fragile. The 
superconducting wire has zero electrical resistance below 4K. Therefore, it has to be cooled to 
reduce the electrical resistance. To achieve that, the superconducting magnet is immersed in liquid 
helium (-269°C or 4K). The wire and liquid helium are in a big container, which is surrounded by 
vacuum and then liquid nitrogen (77K) which acts as a thermal buffer between the outside 
temperature (293K) and liquid helium. Followed by liquid nitrogen, there is a vacuum region filled 
between liquid helium and liquid nitrogen which has several layers of reflective mylar film to 
reflect thermal photons and then block any heat from entering the magnet.  
      Shim coils come after the magnet (Figure1-19). The purpose of shim coils is to adjust the 
homogeneity of the B0 magnetic field.  Hence, shim coils generate a small magnetic field opposed 
to the B0 inhomogeneous and cancel out any inhomogeneity (Figure 1-20)27.  
       The transmitter section contains several parts namely, r.f synthesizer, pulse gate, pulse 
programmer, and amplifier. Each part of the transmitter has its own function. The r.f synthesizer 
produces an electrical signal with a specific frequency. Under the control of pulse programmer, 
the r.f pulses are allowed to pass through the pulse gate. The amplifier is utilized to increase the 
amplitudes of r.f pulse before transmitting to the probe.  
      The probe is a distinctive part of NMR spectrometer and the way to communicate with the 
sample. Moreover, it is the main difference between solid and solution state NMR spectrometers. 
The probe consists of r.f coil, sample spinner, temperature control circuity, and gradient coils. The 
probe’s tasks are:  
1. To hold the sample in appropriate place where the magnetic field is homogenous so we can 
acquire a spectrum with a narrow line (Figure 1-21). When the sample is placed in a more 
inhomogeneous field, the result spectrum will be broad as shown in (Figure 1-22).  
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2. To send r.f energy to the sample. 
3. To detect the signal from the sample. 
The receiver is responsible for detecting and converting the signal to readable data.  
1.8 The basics of quantitative NMR (qNMR) 
      The first application of qNMR was in 1963 by Jungnickel and Forbes 29and Hollis29. 
Jungnickel and Forbes determined the intramolecular proton ratio in different organic solvents 
while Hollis determined the amount of three components namely: aspirin, caffeine, and 
phenacetine in separate mixtures. In the past decades, qNMR was an efficient tool to quantify 
essentially organic chemicals and proton qNMR specifically was mostly commonly used. 
Nowadays, qNMR is becoming a well-established and widely popular technique among numerous 
fields such as the  pharmaceutical and food industries 30–32. When proton qNMR is applied to study 
complex molecules, which have multiple protons in their structure, the proton qNMR becomes 
relatively challenging because of peaks overlapping. Therefore, the usage of other active nuclei 
would be a suitable option to perform  qNMR accurately33–35.     
 In order for any NMR peak to be quantifiable, certain requirements have to be obtainable 
in that peak. First of all, the line shape of the peak has to be integrated and has a good resolution. 
Moreover, the relaxation time should be 5*T1 with the purpose of getting a complete relaxation 
and avoiding intensity distortion. Lastly, the quantified NMR peaks should be in a similar 
environment.   
      Several advantages of qNMR allow this technique to compete among other 
chromatographic methods. For instance, the area of integrated signal peak is directly proportional 
to the number of nuclei contributing to the signal. It is a non-destructive and highly predictable 
technique in which no intensity calibration is required. It has short measuring times and fast 
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acquisition. Sample preparation and handling are relatively easy. In NMR spectroscopy, the 
characterization of analytes in mixtures are routinely conducted without a need for prior isolation 
or purification.  
      The fundamental theory of qNMR is based on the direct proportional relationship between 
the signal response (integrated signal area) (𝐼𝑥) for a compound X and the number of nuclei (𝑁𝑥) 
producing the NMR signal36.  
      qNMR principle is governed by Equation (1-6), where 𝐾𝑠 represents the NMR 
spectrometer constant. For a given NMR spectrum, 𝐾𝑠 is identical for all resonance lines so the 
ratio of Ix and Iy  is equivalent to the ratio of Nx and  Ny Equation (1-7). The molar ratio of a given 
compound in a mixture of analytes can be determined using Equation (1-8), where nx/ny is the 
molar ratio of compound x and y. Hence, the mole fraction of compound X in a mixture of 
components m can be found by using Equation (1-9). An internal standard with known purity is 
required in order to determine the purity of compound x in a mixture using Equation (1-10), where 
px, Mx , and mx are the purity, the molecular weight, and the mass of compound X respectively. 
Whereas pstd, Mstd , and mstd are the purity, the molecular weight, and the mass of the standard.  
 
                𝐼𝑥=𝐾𝑠×𝑁𝑥                                          (1-6) 
              
𝐼𝑥
𝐼𝑦
=
𝑁𝑥
𝑁𝑦
                                                (1-7) 
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Table 1-1. Nuclei of interest in this dissertation 
 
 
 
          
 
 
 
 
 
 
Nuclei  neutron proton Nature 
abundance 
Net spin 
1H 0 1 99.985% ½ 
2H 1 1 0.015% 1 
12C 6 6 98.9% 0 
13C 7 6 1.1% ½ 
10B 5 5 19.97% 3 
11B 6 5 80.0% 3/2 
19F 10 9 100% ½ 
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Figure 1-1.An effect of applying external magnetic field 
Figure 1-2. Zeeman splitting. The splitting grows 
proportionally to the magnetic field  
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Figure 1-3. Lamor precession. The spin magnetic moment experiences a torque due to 
the presence of the magnetic field which causes it to precess 
Figure 1-4. Application of the secondary magnetic field causes precession about that 
axis, causing the net magnetization to rotate into the x-y plane 
B0 
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Figure 1-5. Relaxation process of the net magnetization to equilibrium when B1 is turned off  
 
 
 
 
 
 
 
 
 
 
 
Figure 1-6. Converting FID from time domain to frequency domain 
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Figure 1-7. Energy splitting diagram for quadrupole nuclei when external magnetic field applied 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-8. NMR spectrum. Important parameters are the line position, intensity, and width 
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Figure 1-9. The longitudinal spin magnetization builds up to establish a new equilibrium state 
 
 
 
Figure 1-10. The magnetization will rotate from z-axis to –y-axis when an r.f pulse is applied 
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Figure 1-11. T1 and T2 as a function of molecular correlation time 
 
 
 
 
 
 
 
 
 
 
Figure 1-12. Inversion recovery experiment to measure T1 
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Table 1-2. The approximate relative magnitudes of NMR interactions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interaction Magnitude(Hz) 
Zeeman 108 
Quadrupolar 106 
Chemical shift 103 
Dipole 103 
J-coupling 10 
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Figure 1-13. Common NMR interactions including interactions between the spin and magnetic 
fields and the interactions between spins  
 
 
 
 
Figure 1-14. The magnitudes of NMR interactions in different sample phases due to rotational 
averaging  
27 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-15. Solution NMR spectrum gives a single narrow line due to fast to rotational 
averaging  
 
Figure 1-16. Amorphous SSNMR spectrum gives a broad peak with an asymmetric line shape 
due to the presence of all possible orientations of the crystallites 
Figure 1-17. Single crystal SSNMR spectrum with the crystal sample oriented with different 
orientations  
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Figure 1-18. Averaging of rotational interactions in NMR spectroscopy 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-19. NMR spectrometer components 
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Figure 1-20. The shim field creates an opposing magnetic field to cancel out 
inhomogeneity in B0 over the volume of the sample  
Figure 1-21. A homogenous magnetic field results in a narrow NMR spectrum 
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Figure 1-22. An inhomogeneous magnetic field results in a broader 
NMR spectrum 
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Part I. APPLICATIONS OF SOULTION STATE NMR SPECTROSCOPY IN 
PHARMACEUTICAL SCIENCES 
 Overview  
Drug delivery is a method or a process for transporting a pharmaceutical compound to the 
part of the body where it’s needed. Delivering the drug to the human body is an important 
component in pharmaceutical sciences. Several drug delivery systems have been investigated and 
utilized for a long period of time. These include oral, topical, and injection. Although these 
systemic administration methods are common and prevalent, they have some drawbacks. Some 
drugs may not travel easily through cells and tissues while others may lose their efficiency as they 
pass through the digestive system. Some drugs might cause side effects on the heathy tissues and 
organs. Moreover, some drugs may have solubility issues since they are partially soluble or not 
soluble at all in biological fluids.  
In order to avoid these drawbacks, new drug delivery systems, which use a carrier based 
system as an alternative route for systemic administration system, are being developed.  There are 
several types of carrier based systems and each type has its unique advantages and disadvantages. 
In this dissertation, we focused our studies on nano/micro formulations as a drug delivery system, 
specifically when the drug is encapsulated inside a nano/micro formulation. By going to this smart 
drug delivery system, several advantages can be gained. First, the physical properties of the drug, 
such as solubility, can be improved. The drug can be targeted where it can be delivered to the site 
where it is needed without passing through any organs. Hence, it will eliminate the side effects of 
the drug. Moreover, the release of the drug from nano/micro formulation can be controlled by 
designing the formulation in a certain way so we can have a slow release of the drug over a long 
period of time. Finally, using nano/micro formulation can allow the drug to be triggered in the 
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presence of biomarkers. For example, when there is a cancer cell in human body, there would be 
a slight change in the pH around that cell. When the formulation is close to that cell, it will notice 
a pH change and then release the drug.  
Studying the amount of the drug that is encapsulated inside these formulations and the rate 
of the drug release are critical steps in drug development. We explore the use of qNMR 
spectroscopic technique as a new tool to quantify the amount of the drug encapsulated and released.  
      NMR spectroscopy has become a well-established and widely popular technique among 
pharmaceutical scientists. Nowadays, NMR is routinely used in the identification of drugs, the 
determination of multicomponent drug compositions, isomeric composition determination, drug 
degradation studies, impurities level determination and elucidation of their structure, quality 
assessment as well as counterfeit drugs determination. In part I of this dissertation, several 
applications of NMR spectroscopy in pharmaceutical science will be presented and discussed. 
  In chapter 3, we investigate the potential of a real-time solution-state quantitative boron 
nuclear magnetic resonance (11B qNMR) method for the analysis of boron-containing therapeutics 
molecules and formulations. Thus, a 11B qNMR method was developed and validated for the 
quantification of bortezomib (BTZ). 
In chapter 4, quantitative analysis of fluorinated drug (maraviroc) has been studied in order 
to quantify the amount of the drug released from microparticles into simulated biological fluids 
using fluorine (19 F) NMR Spectroscopy. 
 In chapter 5, NMR spectroscopy was implemented as a characterization tool for 
monitoring the reaction progression.    
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 Objectives  
The overall objectives of this part of the dissertation are: 
1. To develop an accurate, alternative method to misleading drug release profiles in situ using 
NMR spectroscopy.  
2. To validate the methods for 11B and 19F solution-state quantitative nuclear magnetic 
resonance (qNMR) for the real-time quantification of drug release. 
3. To utilize 11B NMR spectroscopy as a characterization tool for the reaction progression of 
the derivative of Phynelboronic acid (PBA).  
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2.1 The basics of quantitative NMR (qNMR) 
      The first application of qNMR was in 1963 by Jungnickel and Forbes 1and Hollis2. 
Jungnickel and Forbes determined the intramolecular proton ratio in different organic solvents 
while Hollis determined the amount of three components namely: aspirin, caffeine, and 
phenacetine in separate mixtures. In the past decades, qNMR was an efficient tool to quantify 
essentially organic chemicals and proton qNMR specifically was mostly commonly used. 
Nowadays, qNMR has become a well-established and widely popular technique among numerous 
fields such as the  pharmaceutical and food industries 3–5. The implementation of qNMR in several 
fields brings more complex molecules, which makes proton qNMR relatively challenging. 
Therefore, the usage of other active nuclei would be a suitable option to perform qNMR 
accurately6–8.     
      Several advantages of qNMR allow this technique to compete among other 
chromatographic methods. For instance, the area of integrated signal peak is directly proportional 
to the number of nuclei contributing to the signal. It is a non-destructive and highly predictable 
technique in which no intensity calibration is required. It has short measuring times and fast 
acquisition. Sample preparation and handling are relatively easy. In NMR spectroscopy, the 
characterization of analytes in mixtures are routinely conducted without a need for prior isolation 
or purification.  
      The fundamental theory of qNMR is based on the direct proportional relationship between 
the signal response (integrated signal area) (𝐼𝑥) for a compound X and the number of nuclei (𝑁𝑥) 
producing the NMR signal9.  
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      The qNMR principle is governed by Equation (2-1), where 𝐾𝑠 represents the NMR 
spectrometer constant. For a given NMR spectrum, 𝐾𝑠 is identical for all resonance lines so the 
ratio of Ix and Iy  is equivalent to the ratio of Nx and  Ny Equation (2-2). The molar ratio of a given 
compound in a mixture of analytes can be determined using Equation (2-3), where nx/ny is the 
molar ratio of compound x and y. Hence, the amount fraction of compound X in a mixture of 
components m can be found by using Equation (2-4). An internal standard with known purity is 
required in order to determine the purity of compound x in a mixture using Equation (2-5), where 
px, Mx , and mx are the purity, the molecular weight, and the mass of compound X respectively. 
Whereas pstd, Mstd , and mstd are the purity, the molecular weight, and the mass of the standard.  
 
                𝐼𝑥=𝐾𝑠×𝑁𝑥                                         (2-1) 
              
𝐼𝑥
𝐼𝑦
=
𝑁𝑥
𝑁𝑦
                                               (2-2) 
             
𝑛𝑥
𝑛𝑦
=
𝐼𝑥
𝐼𝑦
𝑁𝑦
𝑁𝑥
                                            (2-3) 
              
𝑛𝑥
∑ 𝑛𝑖
𝑚
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=
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 ×  100%                (2-4) 
              Px =
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2.2 Validation of qNMR 
2.2.1 Linearity and calibration curve 
       Linearity is described as the concentration range within which a given method provides a 
linear proportional relationship between NMR peaks’ area under curve (AUC) and the molecules 
of interest concentrations. Frequently, calibration curve is established using different 
concentrations prepared by serial dilution of a standard. NMR peak’s area under curve is then 
plotted in relation to the molecules of interest concentrations. The intercept, slope, and coefficient 
of determination (R2) values are obtained by linear regression analysis. 
 2.2.2 Limit of quantification (LOQ) and limit of detection (LOD) 
      Limit of quantification is the lowest concentration of a substance in a sample that can be 
quantitatively identified precisely, whereas the limit of detection is the lowest amount of a 
substance that can be detected but not quantified. LOQ and LOD values can be determined using 
the numerical method based on Equations (2-6&7) or can be determined visually from the spectra. 
The LOQ and LOD values obtained from NMR are not as precise as other analytical technique 
such as HPLC, but it is still comparable.  
 
LOD = 
3.3×𝜎
𝑆
    (2-6) 
LOQ = 
10×𝜎
𝑆
    (2-7) 
 
2.2.3 Specificity 
      Specificity is the method’s ability to identify the analyte peak in the presence or absence 
of other contaminants. It is one of the first parameters that has to be evaluated to discover whether 
the method is appropriate or not.    
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2.2.4 Accuracy and Precision 
       The accuracy of an analytical method describes the closeness of measured values (sample 
values) to a true value (population value) with no systematic errors. Precision represents the 
agreement in the measurements when repeated with no random errors.   
2.2.5 Robustness 
      The robustness of an analytical method measures the ability of the method to stay 
unaffected when certain parameters change. The robustness of qNMR method can be analyzed by 
varying different parameters such as: temperature, relaxation delay, magnetic field, pulse width, 
and proton decoupling. Results should be reported as relative standard error %RSE. According to 
ICH guidelines, for the robustness determination, %RSE should be less than 2%. 
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3.1 Introduction  
      Boron is an interesting element, which is located in group 13. It has atomic number five 
and an electronic configuration of [He] 2s2 2p1. Boron is a metalloid, which has properties of a 
metal and nonmetal. Moreover, it is a neighbor for carbon in the periodic table.  Because of the 
closeness to the carbon, boron and carbon share some useful similarities as well as important 
differences. Like carbon, boron can form a small size compound, which is suitable for approaching 
key binding sites. The most fascinating feature of boron from a chemist’s point of view is that 
boron forms a very complex series of hydrides just as carbon does. It also can form four covalent 
bonds like carbon.  Although boron and carbon share some noteworthy properties, there are 
remarkable differences between their properties. While boron hydrides are composed of clusters 
and cages, carbon hydrides are composed of chains and rings. Since boron is a metalloid, it behaves 
like a metal when it forms oxides and salts such as B2O3 and B2(SO4)3 respectively.  On the other 
hand, it behaves as a nonmetal when it forms acids such as boric acid B(OH)3. Even though boron 
is a trivalent metal, it does not act like pure metal. It has a strong affinity to electrons due to the 
empty Pz orbital (Figure3-1)
10. Hence, boron and most of its compounds are classified as electron-
deficient, which results in unusual structures. Due to the unique charge distribution of boron 
compounds, they can form non-covalent bonds, which is an essential feature for biochemical 
reactions.  Carbon compounds on the other hand typically form covalent bonds. Additionally, 
boron compounds show distinctive hydrophobic behavior, which makes them gain an interesting 
attraction to organic molecules. 
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  Boron is produced mainly in Turkey and the United States. Until recently, the use of 
boron-containing compounds was mostly limited to common household appliances such as 
borosilicate glass, fiberglass textiles and insulation, washing powders, tile glazes and boric 
acid11,12. Recent decades have witnessed significant progress in boron chemistry, which have 
greatly expanded the use of boron-containing compounds from material to therapeutics. 
Researchers and the pharmaceutical industry are currently interested in boron compounds as an 
alternative to carbon compounds, which may lead to a new generation of boron drugs. Today, 
boron-based therapeutics are being widely investigated and represent an emerging new class of 
drug molecules. These molecules possess several biomedical applications as imaging agents for 
both optical and nuclear imaging, as well as therapeutic agents with anticancer, antiviral, 
antibacterial, antifungal and other disease-specific activities13.  
      Boron-containing molecules have been overlooked as potential therapeutics primarily 
because of the misconception that the element boron is toxic. The “fear” of boron may have 
generated from boric acid, an ingredient for ant poison. However, it is well established that boric 
acid has an LD50 of 2660 mg/Kg (rat, oral), which resembles table salt 3000 mg/Kg (rat, oral)
14. 
Moreover, boric acid is currently used as preservative in eye wash and vaginal creams15. Other 
studies have reported that boric acid inhibits the proliferation of prostate cancer cell lines, DU-145 
and LNCaP, in a dose-dependent manner16,17. Furthermore, boron is known to be an essential plant 
nutrient that is present in many nuts, vegetables and fruits. This might explain the 0.3-4.2 mg daily 
intake of boron by Americans, according to Reiney et al18.  Further evidence of the lack of an 
inherent toxicity of the element boron has been demonstrated by the recent FDA approval of boron 
containing drugs, such as Crisaborole (2016), Tavaborole (2014) and Bortezomib (2003). Many 
more boron-containing drugs are currently undergoing clinical trials and have demonstrated very 
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promising safety and efficacy profiles. For example, Talabostat (PT100), a specific inhibitor of 
dipeptidyl peptidase-4 (DPP4), is a boron-containing compound currently in a phase III clinical 
trial for patients with stage IIIB/IV non-small-cell lung cancer who have failed a platinum-based 
chemotherapy regimen19. In a recently completed phase III clinical trial, Ixazomib, a peptide 
boronic acid derivatives, in combination with lenalidomide-dexamethasone significantly improved 
the overall survival rate and the progression-free survival in patients with relapsed/refractory 
multiple myeloma20. 
 Boron neutron capture therapy (BNCT), a form of cancer radiation therapy, is gaining 
renewed attention due, in part, to significant progress in novel boron compounds and boron cluster 
chemistry21. For instance, boronophenylalanine (BPA)-based compounds have been investigated 
in clinical trials for the treatment of glioblastoma as well as head and neck tumors22,23. Another 
BNCT clinical trial has shown the potency of this therapy against malignant melanoma and the 
potential for in-hospital neutron irradiator (IHNI) to enable the delivery of BNCT in hospitals24. 
Furthermore, boron clusters such as closomers (derivatives of B12OH12) are being considered as 
novel BNCT delivery strategy25. Boron containing compounds are also receiving special interest 
for their potential in diagnosis and imaging13. 
 In vitro, the study of drug release kinetics from nano/microformulations is an important 
step to quality control of drug delivery system.  Due to the small size of nano/microformulations, 
it is very challenging to separate them from release media efficiently. Among other experimental 
methods, the dialysis method remains one of the most commonly used methods to study drug 
release kinetics from nano/microformulations26. The widespread use of the dialysis method is 
probably due to its simplicity, the lack of additional separation required between released drug and 
formulation debris, as well as the ability to analyze dialysis samples by, practically, any analytical 
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method (UV-Vis, HPLC, LC-MS, NMR, etc.). Nonetheless, numerous studies have shed some 
light on the dialysis method’s limitations for the accurate, real-time approximation of drug released 
from nano/microformulations27,28. Based on comparing the experimental results and simulation of 
dialysis method, the result of release quantification can be entirely misleading29.  This limitation 
could be due to the two-step process involved in the dialysis method. To overcome this pitfall, the 
researchers thought that an ideal solution must be initiated and established for fast, accurate and 
real time method. Various strategies, including numerical deconvolution28, optical techniques30 
and mathematical modeling29 have previously been proposed. Facts discussed above motivated us 
to investigate the use of qNMR, as an alternative to the dialysis method, for the accurate and real-
time quantification of boron contacting drugs release from microparticles formulation. 
3.2 General Research Approach 
      In the current study, we investigate the potential of a real-time solution-state 
quantitative boron nuclear magnetic resonance (11B qNMR) method for the analysis of boron-
containing therapeutics molecules and formulations. Thus, a 11B qNMR method was developed 
and validated for the quantification of bortezomib (BTZ) (Figure3-2)31.  BTZ is the first 
proteasome inhibitor approved for use in human for the treatment of multiple myeloma32. The 
developed qNMR method was then used to study the real-time release of BTZ from a spray-dried 
alginate microparticle formulation. Furthermore, BTZ real-time release kinetics were compared to 
the traditional dialysis method, generally used for drug release studies in micro/nanoformulations. 
With the expansion in boron-focused pharmaceutical research, along with the expected approval 
of new boron containing drugs, this study may provide an additional tool for the analysis of boron-
based pharmaceutical formulations/compounds. This study may also contribute to the growing 
discussion on the use and validity of dialysis methods for evaluating drug release kinetics. In fact, 
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among other experimental methods, the dialysis method remains one of the most commonly used 
methods to study drug release kinetics from nano/microformulations26.  
3.3 Quantitative NMR theory and pharmaceutical applications 
Nuclear magnetic resonance (NMR) spectroscopy is a substantial, powerful, and broadly 
used form of spectroscopy in analytical method development33,34. Over the past decades, NMR has 
proved to be a remarkably successful analytical technique for structural determination. In contrast 
to other spectroscopic methods, NMR spectroscopy is a non-destructive and highly predictable 
technique in which no intensity calibration is required. It can have short measuring times, and 
sample preparation and handling are relatively easy. Furthermore, the characterization of analyte 
mixtures can be routinely conducted in NMR spectroscopy without a need for prior isolation or 
purification. The fundamental theory of qNMR is based on the direct proportional relationship 
between the signal response (integrated signal area) (𝐼𝑥) for a compound X and the number of 
nuclei (𝑁𝑥) producing the NMR signal
9.  
𝐼𝑥 = 𝐾𝑠 × 𝑁𝑥   (3-1) 
qNMR is governed by equation (3-1), where 𝐾𝑠 represents the NMR spectrometer constant. 
For a given NMR spectrum, 𝐾𝑠 is identical for all resonances lines, which allows the determination 
of the mole fraction of a given compound in a mixture of analytes35.  
Owing to the wide range of possible applications, the remarkable accuracy, robustness and 
less experimental hurdles, qNMR is becoming a well-established and widely popular technique 
among pharmaceutical scientists. Nowadays, qNMR is routinely used in the identification of drugs, 
the determination of multicomponent drugs composition, isomeric composition determination, 
drug degradation studies, impurities level determination and elucidation of their structure, quality 
assessment as well as the counterfeit drugs determination36–39. Commonly qNMR nuclei used in 
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pharmaceutical applications are 1H and 13C40,41. This is partly due to the high proportion of carbon 
and hydrogen atoms in natural and synthetic compounds, compared to other NMR active atoms. 
Other studies have investigated NMR active heteroatoms such as 19F, 31P and 15N in the 
quantification and characterization of therapeutic molecules6,7,42. In this study, we investigate the 
use of 11B qNMR for the characterization and quantification of boron-containing drugs. Boron has 
two naturally occurring isotopes (10B [20%] and 11B [80%]) and both are detectable by NMR with 
spins values greater than 1/2. In fact, 11B has a spin of 3/2, a quadrupole moment of 4.06 fm2 and 
a relative gyromagnetic ratio of 0.32 (compared to 1H). 10B has a spin value of 3 a quadrupole 
moment of 8.46 fm2, and a relative gyromagnetic ratio of 0.10743.  The low quadrupole moment 
of 11B makes it a better nuclei for qNMR of non-enriched samples than 10B. In fact, 11B has a 
higher receptivity (sensitivity relative to 1H) (0.13) and yields sharper signals compared to 10B 
(0.0039)44–46. One major advantage of 11B qNMR is the higher natural abundance of 11B (80%) 
compared to 13C (1.1%)4743. In addition, 11B qNMR offers the advantage of a wider range of 
chemical shift (-120 to 90 ppm) compared to 1H. In fact, 1H has a narrow range of chemical shift 
(typically 0 to 15 ppm), which often leads to signal overlap and increased spectral complexity due 
to coupling of neighboring protons48 (Figure3-3). Furthermore, due to the low density of boron 
atoms in currently approved boron containing therapeutic molecules (one B atom/molecule), 11B 
qNMR can avoid interference from homonuclear coupling as well as signal overlap49. Moreover, 
because of the lack of boron atoms in solvents typically used in pharmaceutical applications, 11B 
qNMR experiments can virtually be performed in any solvent without the risk of solvent signal 
interference, given that the solubility and stability are established in those solvents. This versatility 
in 11B qNMR solvent choice is more economically favorable as this could avoid the use of special 
and/or expensive solvents. 
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3.4 Material and methods 
3.4.1 Reagents  
Bortezomib was obtained from ZhongShuo Pharmaceutical Technology Development 
Co.,Ltd. (Beijing, China). Boron trifluoride diethyl etherate (BF3.OEt2), acetonitrile, methanol, 
ethanol, acetone, dimethyl sulfoxide (DMSO), chloroform-d (CDCl3), boric acid, 4-
propylphenylboronic acid (PBA) and alginic acid sodium salt (from brown algae, medium 
viscosity) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Deionized water (DI water) 
was obtained through a Millipore Milli-Q water purification system (Millipore Corp., Danvers, 
MA) and all other chemicals were of analytical grades and used as obtained from suppliers. 
3.4.2 11B qNMR method development 
In this study, the integrated 11B qNMR peak area of BTZ was of interest in order to 
accurately quantify the amount of drug. 11B qNMR spectroscopy was carried out on a Varian 400 
MHz spectrometer (Palo Alto, CA, USA) with a Varian 2-channel probe. VnmrJ software (version 
4.2A) was used for data acquisition and processing. The 11B spectra were acquired at frequency 
128.268MHz. Wilmad® quartz NMR tubes (600 MHz, diam. 5 mm, L7 in, Sigma-Aldrich, St. 
Louis, MO, USA) were used for spectral acquisition in order to eliminate the contribution of 
borosilicate glass in the spectrum. An inversion recovery experiment was performed to optimize 
the spin-lattice relaxation time, which was found to be 0.4s. We found that T1 is around 0.08s 
Usually, most NMR active nuclei are fully relaxed after 5 times of T135. According to the Equation 
(3-2) below, the linewidth of the NMR signal is directly dependent on T2* (the apparent spin-spin 
relaxation time). Large molecules such as a polymer tend to have very small T2 values. 
𝐿𝑖𝑛𝑒 𝑤𝑖𝑑𝑡ℎ = (𝜋𝑇2 ∗) 
−1       (3-2) 
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Therefore, it is expected that the integrated peak for a polymeric formulation of BTZ will 
be very broad in comparison to free BTZ (in solution), due to slow tumbling6. Shimming was 
applied to each sample to maintain the same linewidth in each spectrum. For all 11B NMR 
experiments, the number of accumulated transients, the pulse width and the complex point were 
512 and 90° (11μs), 2048 respectively. While the spectral width and FID acquisition time were 
2565.7 and 0.080s. The total acquisition time for each spectrum was around five minutes.   The 
sample spinning frequency was 20 Hz, which is a typical way of acquiring NMR spectra to 
improve the resolution, with no observable sidebands.  Neither zero-filling, window function nor 
proton decoupling were applied. Experiments were performed in triplicate and average integrated 
peak area values were determined. BF3.OEt2 (15% in CDCl3) was used as 
11B q-NMR external 
standard and its chemical shift (δ ~ 0 ppm) and peak resolution were assessed prior to any BTZ 
spectral acquisition. Typically, 650 μL of BTZ sample are placed in the quartz NMR tubes and 11B 
NMR experiments are conducted at 37ºC  using a standard VT, unless specified otherwise. 
Baseline correction, phase adjustment, and integral calculation were carried out manually using 
MestReNova Lite (11.02.2, Escondido, CA, USA)  and Matlab (2013-rdp, Natick, MA, USA).  
Following a screening in DI water, acetonitrile, methanol, ethanol, acetone, dimethyl 
sulfoxide (DMSO) and chloroform-d (CDCl3), methanol was selected as the optimal solvent for 
BTZ 11B qNMR method development and validation. The solvent screening was conducted by 
assessing the 11B spectrum resolution of BTZ samples (50 mg/ml) of BTZ prepared in these 
solvents. The solubility of BTZ in the screening solvents and the intensity of any eventual boric 
acid contaminant’s 11B NMR peak were also considered as critical parameters in the optimal 
solvent selection process. BTZ samples were prepared in methanol at concentrations ranging from 
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0.19 to 50 mg/ml (0.49 to 130.15 mM) by serial dilutions of a stock solution (50 mg/ml). When 
not in use, samples were sealed and kept under refrigeration at – 20 ºC.  
3.5 Validation of 11B qNMR Method 
11B qNMR method was validated according to the International Conference on 
Harmonization (ICH) guidelines Q2(R1)50. Thus, several parameters (linearity, LOD, LOQ, 
specificity, precision, accuracy and robustness) were evaluated and the statistical variations within 
11B qNMR peak areas and/or BTZ concentrations were presented as percent relative standard error 
(%RSE). ), as expressed in the Equation below. 
%RSE =
𝑠
𝑥 √𝑛
× 100     (3-3) 
3.5.1 Linearity and calibration curve: Linearity is described as the concentration range 
within which the 11B qNMR method provides a linear proportional relationship between 11B NMR 
peaks’ area under curve (AUC) and BTZ concentrations. BTZ calibration curve was established 
using nine different concentrations (0.19- 50 mg/ml) prepared by serial dilution of a standard (50 
mg/ml) in methanol. 11B NMR peak’s area under curve was then plotted in relation to BTZ 
concentrations. The intercept, slope, and coefficient of determination (R2) values were obtained 
by linear regression analysis in GraphPad (version 6.0, La Jolla, CA, USA). 
3.5.2 Limit of quantification (LOQ) and limit of detection (LOD): Limit of 
quantification is the lowest concentration of a substance in a sample that can be quantitatively 
identified precisely, whereas the limit of detection is the lowest amount of a substance that can be 
detected but not quantified. LOQ and LOD values were determined using the numerical method 
based on Equations (3-4&5). The standard deviation of the response [σ] and the slope of the 
calibration curve [S] were obtained from the linear regression performed in GraphPad (version 
6.0, La Jolla, CA, USA). 
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LOD = 
3.3×𝜎
𝑆
  (3-4) 
LOQ = 
10×𝜎
𝑆
  (3-5) 
3.5.3 Specificity: Specificity is the method’s ability to identify the analyte peak in the 
presence or absence of other contaminants. In this study, 11B qNMR method’s specificity was 
tested in the presence of boric acid and 4-propylphenylboronic acid (PBA). Thus, BTZ’s 11B 
qNMR spectrum was acquired and compared to spectra containing the contaminants. A method 
specific to BTZ should clearly distinguish the drug from the contaminants, in term of chemical 
shift values. 
3.5.4 Accuracy and Precision: The accuracy of an analytical method describes the 
closeness of measured values (sample values) to a true value (population value) with no systematic 
errors. Precision represents the agreement in the measurements when repeated with no random 
errors.  The accuracy of 11B qNMR method was evaluated using four (4) quality control (QC) 
samples (3, 5, 11 and16 mg/ml) and results were expressed as percent mean recovery and percent 
relative standard error (%RSE). The same QC samples were utilized to assess the intra-day and 
inter-day precision of 11B qNMR and results were reported as %RSE. Each QC sample was 
analyzed in triplicate (n=3) throughout the accuracy and precision study. 
3.5.5 Robustness: The robustness of an analytical method measures the ability of the 
method to stay unaffected when certain parameters change. The robustness of 11B qNMR method 
was analyzed by varying four (4) parameters including: temperature (⁰C), relaxation delay (s), 
pulse width (µs), and proton decoupling. Each experiment was performed in triplicate and results 
are reported as %RSE. For the robustness determination, %RSE should be less than 2%. 
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3.6 Alginate microparticles preparation 
Alginate microparticle formulation of BTZ was prepared according to the method of Meng 
et al., with minor modifications51. Thus, alginic acid sodium salt and BTZ were added to 40 ml of 
a solution of 15% methanol (in DI water, pH 7.2) at a ratio of 4:1. The mixture was stirred at room 
temperature (25 ºC) until both the drug and polymer were completely dissolved. The solution was 
then spray-dried on a Buchi Mini Spray Dryer, Model 290 (Buchi Laboratoriums - Technik AG, 
Flawil, Switzerland). The spray dryer inlet temperature was T=120 ºC, the outlet temperature at 
the collector was 30 ºC, the aspirator was maintained at 85%, the pump rate was 10% and the 
nozzle cleaner was set at 7. Dried microparticles powder was collected from the instrument and 
stored at 4 ºC for further analysis. 
3.7 Physico-chemical characterization 
3.7.1 Size and surface charge: BTZ microparticles size and zeta potential (ζ-potential) 
measurements were conducted by dynamic light scattering (DLS) on Malvern instrument 3600 
Zetasizer Nano (Worcestershire, UK). Practically, 1 ml of sample suspension (in DI water) was 
prepared in disposable size measurement cuvette and briefly sonicated (20 s) by bath sonication 
(Qsonica LLC, Newtown, CT, USA). Surface charge density (ζ-potential) measurements were 
conducted by transferring samples into DTS 1070 zetasizer disposable folded capillary cells 
(Malvern Instruments, Northampton, MA, USA). Size and ζ-potential cuvettes were then placed 
in the cell area and experiments were performed at 25°C on the Zetasizer instrument. Data 
acquisition and analysis were conducted using Zetasizer software (version 6.01, Worcestershire, 
UK). Prior to any DLS measurements, the instrument was calibrated using nanosphere™ size 
standards (60.0±4 nm) and ζ-potential transfer standards (−42.0±4.2 mV), obtained from Malvern 
Instruments (Northampton, MA, USA). 
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3.7.2 Fourier transform infrared spectroscopy (FTIR): IR spectroscopy was conducted 
following published methods52,53. IR spectra were acquired on Nicolet IS10 FTIR instrument 
(Thermo Fisher Scientific, Madison, WI, USA) equipped with a Zinc selenide (ZnSe) crystal. The 
instrument was used in the Attenuated Total Reflectance (ATR) mode. A resolution of 4 cm-1 and 
a sample scan of 228 were fixed as basic acquisition parameters. Transmittance IR spectra were 
acquired between 4000 and 650 cm-1. For better spectral resolution, all samples were allowed to 
make intimate contact with the ATR ZnSe crystal’s surface by pressing them with a built-in 
pressure clamp. FTIR spectra were collected and analyzed with OMNIC Specta Software (Thermo 
Fisher Scientific, Madison, WI, USA). Typically, the average IR spectrum acquisition time was 6 
minutes.   
3.7.3 Scanning electron microscopy (SEM): To analyze BTZ microparticles’ 
morphology, SEM imaging was conducted on a Field-Emission Environmental SEM Philips XL30 
instrument (Hillsboro, OR, USA). Thus, a small amount of dried microparticles was sprayed onto 
a stub covered with an adhesive conductive carbon tab. Excess material was removed using a 
paintbrush and the sample was sputter coated with a thin layer of gold. Images were acquired at 
an accelerating voltage of 5 kV6.  
3.7.4 Drug loading (%LD): We have previously explored the use of NMR for drug 
encapsulation and loading determination52. In this study, BTZ percent loading (w/w) into alginate 
microparticles was determined by 11B qNMR. Briefly, 15 mg of alginate microparticles are 
dispersed in 600 μL of methanol and the mixture is sonicated for 5 minutes and stored at 4 ºC for 
24 h, to allow a complete release of BTZ from the microparticle formulation. The mixture is further 
transferred into a quartz NMR tube and 11B NMR experiment is performed on a Varian 400 MHz 
spectrometer (Palo Alto, CA, USA), as explained above. The experiment is conducted in triplicate 
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and the average BTZ concentration is determined from a calibration curve, based on the 11B NMR 
spectrum’s area under curve (AUC). Percent %LD is then determined through Equation (3-6). 
%LD =
Average BTZ concentration (mg/ml)
 Alginate microparticle concentration (mg/ml)
× 100  (3-6) 
 
3.8 Drug release kinetics 
One potential benefit of the 11B qNMR method is accurate and real-time quantification of 
boron-containing drugs’ release from nano/microparticles formulations. In this study, BTZ real-
time release from an alginate microparticle formulation was assessed by 11B qNMR and the release 
profile was compared to a control condition performed in a dialysis bag. Briefly, a homogenous 
dispersion of alginate microparticles (25 mg/ml) was prepared in methanol and immediately 
transferred into a quartz NMR tube. Time dependent BTZ release (% drug release) was further 
determined by acquiring 11B qNMR spectra at predetermined time points (0.5, 1, 2, 4, 8, 16 and 
24 h), at 37 ºC. In a separate experiment, an alginate microparticle sample was prepared at 25 
mg/ml in methanol and immediately placed into a dialysis bag (Spectra/Por® Float-A-Lyzer G2, 
MWCO 8-10 kD; Spectrum Laboratories, Inc., Rancho Dominguez, CA, USA). The dialysis tube 
was further immersed into a methanol bath (15 ml), and the mixture was placed in a thermostatic 
water bath at 37 ºC, under shaking at 60 rpm. Sample aliquots (1 ml) were collected at 
predetermined time points (0.5, 1, 2, 4, 8, 16 and 24 h) from the receiver chamber and BTZ 
concentration was determined by 1B qNMR. The sink condition was maintained by adding 1 ml 
of free methanol solution in the outer dialysis compartment following each sample collection. All 
experiments were conducted in triplicate (n=3) and the time dependent BTZ release (% drug 
release) curve was determined from the calibration curve (Figure 3-4), based on the 11B NMR 
spectrum’s area under curve (AUC).  
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The model-independent mathematical approach was applied to assess the similarity or 
differences of BTZ release profiles between the dialysis and NRR tubes. Thus, a pair-wise 
comparison of both release curves was conducted using the US FDA similarity (𝑓2) and 
dissimilarity (𝑓1) factors. 𝑓1 measures the percent error while 𝑓2 measures the sum-squared error 
between a test and reference compound’s overall time points52.  According to FDA guidelines, 𝑓1 
values lower than 15 (0-15) and 𝑓2 values higher than 50 (50-100) support the similarity of two 
dissolution or release profiles. Consequently, 𝑓1 and 𝑓2 values deviating from those ranges support 
a significant difference between two dissolution or drug release profiles54.  
𝑓1 = (
[∑ |𝑅𝑗−𝑇𝑗|
𝑛
𝑗=1 ]
[∑ 𝑅𝑗
𝑛
𝑗=1 ]
) × 100                                                                (3-7) 
𝑓2 = 50 × log {[1 + (
1
𝑛
)∑ |𝑅𝑗 − 𝑇𝑗|
2𝑛
𝑗=1 ]
−0.5
× 100}                       (3-8) 
In Equations (3-7&8), n represents the sampling number, R and T are the percent dissolved of the 
reference and test products, respectively, at each time j. Furthermore, to elucidate BTZ drug release 
mechanism from alginate microparticles, various release kinetics models including zero order, first 
order, Weibull, Korsmeyer-Peppas, Higuchi, Hixson–Crowell, Hopfenberg and Baker–Lonsdale, 
were fitted to the release profiles. The appropriate (optimal) release kinetic model was selected 
based on higher coefficient of determination (R2) and lower Akaike Information Criterion (AIC) 
values54. AIC value is typically used to measure the goodness of fit between different models, 
based on maximum likelihood55,56.   
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3.9 Results and discussion 
3.9.1 Solvent screening for 11B qNMR method development 
Figure 3-4 is a summary of BTZ 11B NMR spectra acquired in various screening solvents. 
Solvents were screened in order to identify the optimal solvent capable of solubilizing BTZ and 
yielding a single, not noisy, and well-resolved 11B NMR peak. It was observed that BTZ (non-
mannitol formulated) does not dissolve in DI water, acetonitrile and acetone. The lack of solubility 
in water could be due to BTZ’s hydrophobicity (logP = 1.53). Furthermore, 11B NMR of BTZ 
dispersion in those solvents did not yield any well-resolved detectable NMR signal.  
Although BTZ was completely dissolved in DMSO, CDCl3 and ethanol, the resulting 
11B 
NMR signals were very broad and noisy. In addition, a strong boric acid peak (δ = 19 ppm) was 
observed in 11B NMR signal acquired in ethanol indicating possible reactivity with the solvent. 
Conversely, methanol was found to, not only, completely dissolve BTZ, but yielded a symmetrical, 
well-resolved and detectable 11B NMR signal with almost no boric acid peak. The BTZ chemical 
shift in methanol was δ = 13 ppm. Similar findings were also reported by Tabrizi et al. following 
BTZ screening in deuterated water (D2O), saline solution, methanol, acetonitrile plus 20% D2O 
and DMSO57. BTZ signal was well resolved in methanol probably due to the solvent’s lower 
viscosity (0.545 mPa.s) compared to that of DMSO (2.0 mP.s), ethanol (1.074 mPa.s) and CDCl3 
(0.57 mPa.s). In fact, it is well known that as the NMR solvent’s viscosity increases, the molecular 
tumbling slows down and a line broadening occurs in the spectrum due to the quadrupole splitting 
(as observed most readily in the spectrum of BTZ in DMSO)58,59. Therefore, a less viscous solvent, 
such as methanol, that favors a faster correlation time would be preferred for these kinds of studies. 
In addition to the viscosity effect, BTZ peak broadening could be due to the formation of a 6-
membered heterocyclic ring known as boroxine. Boronic acid containing molecules such as BTZ 
57 
 
are well known to self-condensate and easily undergo boroxine formation, which substantially 
reduces molecular tumbling and leads to NMR peak broadening60–64. Boroxine formation in BTZ 
is perhaps more favorable in hydrophobic solvents and that may also explain the difference in BTZ 
peak resolution between CDCl3 and Methanol, although both solvents have similar viscosity 
values64.  
Furthermore, it was shown that BTZ boroxine ring formation induces several differences 
in the spatial orientation of the three boron atoms involved in the self-condensation. In fact, instead 
of the generally accepted planar structure of the boroxine moiety, the boroxine ring was found to 
be consisting of either two boron atoms in trigonal configuration and one in tetrahedral 
coordination and/or two boron atoms in the tetrahedral configuration accompanied by one boron 
atom in a trigonal geometry. These differences in the boron spatial orientation lead to changes in 
the quadrupolar constants and 11B NMR chemical shift, which in turn, could lead to peak 
broadening51. Therefore, all subsequent 11B NMR spectral acquisitions were conducted in 
methanol. Nonetheless, 11B NMR signals of BTZ acquired in methanol were slightly broad. The 
broadening of 11B NMR signals was previously shown to be due to the large quadrupolar moment 
of boron (11B) nuclei61.  
3.9.2 Linearity, detection and quantification limits 
The 11B qNMR method was developed and validated based on ICH Q2(R1) guidelines50. 
The method was linear in the concentration range tested (0.19- 50 mg/ml or 0.49-130.14 mM) and 
the coefficient of determination (R2) was 0.9995 (Figure3-5). The method’s LOD and LOQ were 
0.72 mg/ml (1.87 mM) and 2.17 mg/ml (5.65 mM), respectively. These values were significantly 
higher than values reported for UV spectroscopy (LOD = 0.099 μg/ml and LOQ = 0.301 μg/ml)65 
and HPLC (LOD = 0.084 μg/ml and LOQ = 0.25 μg/ml)62 methods of BTZ. Nonetheless, the LOD 
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and LOQ values obtained were consistent with the range of other qNMR methods reported in the 
field of pharmaceutical research63,64. In general, qNMR methods have a lower sensitivity compared 
to other analytical methods such as UV spectroscopy and HPLC. In fact, higher LOD and LOQ 
values have previously been reported for 1H qNMR66, 31P qNMR6 and 19F qNMR42 methods 
compared to their respective HPLC methods67–69. Nonetheless, following the intravenous 
administration of a 1.3 mg/m2 dose, the median estimated maximum plasma concentration of 
Bortezomib was 509 ng/mL (ranging from109 to 1300 ng/mL)70. Therefore, the current 11B qNMR 
method will only be relevant for the detection of Bortezomib plasma concentration in certain 
patients with high plasma concentration of the drug (between 720 ng/ml and 1300 ng/mL) and 
might not be applicable to the patients population with lower plasma centration of the drug 
(between 109 ng/mL and 720 ng/ml). 
3.9.3 Specificity  
The 11B qNMR method was found to be specific for BTZ. In fact, boric acid and PBA 11B 
NMR chemical shifts did not interfere with BTZ’s. Thus, BTZ’s 11B NMR peak was symmetrical, 
had a consistent chemical shift value (δ = 13 ppm) and could accurately be quantified even in the 
presence of other boron containing contaminants. While boric acid spectrum showed a single peak, 
it was observed that PBA’s 11B NMR spectrum shows two distinctive peaks. One of those peaks 
(δ ~ 30 ppm) was attributed to the boron atom in PBA while the chemical shift at ~ 19 ppm was 
assigned to boric acid. The presence of boric acid in PBA could be the result of a partial 
degradation of PBA or a contamination from the supplier. Figure 3-6 summarizes the results of 
11B qNMR method specificity study. 
3.9.4 Precision and accuracy  
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The precision and accuracy results show that 11B qNMR method of BTZ is accurate with 
all percent mean recovery values within 100 ± 10% and %RSE values <2%, for both intra-day and 
inter-day recovery studies (Table 3-1) and (Figure3-7). The method was also precise and %RSE 
values for intra-day and inter-day precision analysis were <2%, for all four QC samples tested 
(Table 3-2). These results were consistent with ICH guidelines and confirmed the closeness of 
agreement (reproducibility) between the AUC values of 11B qNMR spectra for each QC sample. 
3.9.5 Robustness 
The 11B qNMR method’s robustness was assessed by varying critical NMR instrumental 
parameters. According to their previous work on qNMR method validation, Malz et al. showed 
that changes in various NMR parameters can significantly influence the chemical shift, the signal-
to-noise ratio or signal intensity. In this study, the 11B qNMR method was robust and was not 
affected by stepwise changes in temperature, relaxation delay, pulse width and proton decoupling. 
Method robustness results, summarized in (Table 3-3) and (Figures 3-8, 10, 11), show that all 
%RSE were < 2%.  
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3.10 Application of 11B qNMR method for the real-time in vitro release of BTZ from alginate 
microparticles formulation. 
3.10.1 BTZ/Alg microparticle formulation development and characterization:          
  Following the preparation of spray-dried BTZ/Alg microparticles, average particle size 
and ζ-potential measurements were conducted on the Zetasizer Nano instrument. Figure 3-12 
(A&B) summarizes the size and surface charge density analysis of the microparticle formulation. 
Although it is routinely used for nanomaterial characterization, the Zetasizer Nano instrument is 
suitable for microparticles surface charge density and size measurements (≤ 10 μm)71. BTZ/Alg 
microparticles’ average particle size was 2.36 ± 0.19 μm and the polydispersity index (PDI) was 
0.253. These values were consistent with typical average particle size and PDI values observed in 
spray drying72. PDI values lower than 0.05 are characteristic of monodispersed samples73. 
Moreover, PDI values ranging from 0.1 to 0.7 represent nearly monodisperse preparations, 
whereas PDI > 0.7 suggest broadly distributed samples74. Thus, the BTZ/Alg microparticle 
formulation was nearly monodisperse. The microparticles were negatively charged and the average 
ζ-potential was -57.1 ± 2.2 mV. The strong negative charge is probably due to the carboxylate 
group of alginic acid sodium salt, which is expected to be fully deprotonated (ionized) in neutral 
pH conditions (alginic acid’s pKa ~ 3.4 to 4.4 )75. The SEM image (Figure 3-12 C) revealed that 
individual BTZ/Alg microparticles are spherical in shape with varying size and morphology. 
Nonetheless, the average particle size was consistent with the Zetasizer measurements.  
BTZ was successfully encapsulated inside the alginate microparticles and the %LD, 
determined by 11B qNMR, was 30 ± 1.76% w/w. Furthermore, FTIR spectra (Figure 3-13) 
confirmed the presence of both the polymer and drug in the microparticle formulation. In fact, the 
BTZ/Alg microparticle IR spectrum showed features between 2800 cm-1 and 2950 cm-1 consistent 
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with the symmetric and asymmetric stretch mode of CH2 in BTZ
53. Bands at 1600 cm-1, 1650 cm-
1, 1500 cm-1 and 700 cm-1 in BTZ/Alg microparticle IR spectrum were attributed to amide I, amide 
II, the B-OH bond and the aromatic ring of BTZ, respectively52,76. The broad band between 3100 
cm-1 and 3700 cm-1 in BTZ/Alg microparticle IR spectrum was assigned to OH stretch in sodium 
alginate52. Likewise, the strong bands at 1010 cm-1 and 1400 cm-1 in BTZ/Alg microparticle IR 
spectrum were due to C–O and C–C stretching vibrations and C–OH deformation vibrations in 
sodium alginate77. All of these features observed in BTZ/Alg microparticle IR spectrum were 
consistent with the bands observed in Alg and BTZ IR spectra.  
3.10.2 BTZ in vitro drug release and kinetic modeling 
 The drug release profiles from BTZ/Alg microparticles (Figure 3-14) showed distinctive 
differences between the direct 11B qNMR (Figure3-15) and the dialysis methods (Figure 3-16). 
First, a significant burst release of BTZ was observed in the case of direct 11B qNMR 
measurements in the NMR tube, which was suppressed in the dialysis method. Thus, the dialysis 
method might not be able to accurately approximate the early burst release profile from fast 
dissolving (degrading) nano/microparticles drug delivery systems. Secondly, an equilibrium 
(steady state) in BTZ release profile was achieved in the 11B qNMR method at ~ 4 h, while it took 
twice as long (~ 8 h) to reach an equilibrium in the dialysis method. That is, the dialysis method 
might not be accurately approximating the rate of drug release from nano/microparticles drug 
delivery systems. Thirdly, after the steady states are reached (> 8 h), a significant difference in the 
total amount of BTZ released was observed between both methods. Overall, a more than 20% 
difference in the total amount of BTZ released was observed at equilibrium. Moreover, for each 
time point, the dialysis method consistently underestimated the total amount of BTZ released from 
BTZ/Alg microparticles. The significant difference between both drug release profiles was also 
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supported by the model-independent method using the FDA dissimilarity (𝑓2 = 13.85) and 
similarity (𝑓1 = 54.45) factors. According to the FDA guideline, 𝑓1 values lower than 15 (0-15) 
and 𝑓2 values higher than 50 (50-100) show the similarity of two release profiles
54.  The differences 
observed between the dialysis and direct 11B qNMR methods could be due to the two-step process 
required for drug molecules to partition into the receiver compartment in the dialysis method. In 
fact, unlike in the direct 11B qNMR method, the partition of BTZ drug molecules into the dialysis 
receiver compartment is a consequence of the release from the BTZ/Alg microparticle formulation 
into the inner dialysis chamber followed by a diffusion through the dialysis membrane pores. 
Because of this inherent diffusion barrier, there is constantly a discrepancy in drug concentrations 
across the dialysis membrane. Similar observations were reported using 1H qNMR and 31P 
qNMR6,35.  
Due to the limitation mentioned above, the dialysis method could complicate data 
interpretation and lead to incorrect conclusions regarding the formulation boron based drug release 
kinetics29. In fact, in addition to differences related to the amount of BTZ released in both methods, 
both methods yielded different mechanism and kinetics of drug release (Table 3-4). The drug 
release profile from the direct 11B qNMR method was better explained by the Baker–Lonsdale 
kinetic model (R2 = 0.98 and AIC = 39.661). The Baker–Lonsdale kinetic model was initially 
developed from the Higuchi kinetic model and describes the controlled drug release from a 
spherical matrix. Although the Hixson–Crowell kinetic model also fitted BTZ drug release profile 
from the direct 11B qNMR method with an identical coefficient of determination (R2 = 0.98), this 
model had a significantly higher AIC value (AIC = 55.6) and was therefore rejected. Furthermore, 
the drug release profile from the dialysis method was better explained by the Hopfenberg kinetic 
model (R2 = 0.999 and AIC = 19.031). Traditionally, the Hopfenberg kinetic model has been used 
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to explain drug release profiles from matrix eroding drug particles52. More specifically, 
Hopfenberg kinetic model assumes matrix erosion to be the rate-limiting step of drug release, 
instead of time dependent diffusional resistance (internal or external) to the eroding matrix78.  
3.11 Conclusion 
In this study, we have developed a 11B qNMR method for the simple, rapid, precise and 
real time quantification of bortezomib (BTZ) drug release from an alginate microparticle 
formulation. The 11B qNMR method was validated according to the ICH Q2R(1) guidelines and 
was linear (up to 130.14 mM), specific for BTZ, precise, accurate and robust. The LOD and LOQ 
values were 1.87 mM and 5.65 mM, respectively, and were consistent with the range of other 
quantitative NMR (qNMR) methods. When compared to the traditional, indirect dialysis method 
of in vitro drug release analysis, the direct 11B qNMR method was found to be better at: 
(1) precisely quantifying the early burst released from the microparticle formulation 
(2) accurately determining the rate of drug release from the microparticle formulation as 
well as the time required to attain the equilibrium state 
(3) accurately quantifying the total amount of drug released at each time point. 
Furthermore, the direct 11B qNMR method was found to be relatively easy to setup and less time 
consuming, compared to the dialysis method. As preconceived notions of boron toxicity begin to 
dissipate and more boron containing drugs continue to be approved for therapy, diagnosis or 
imaging, boron specific analytical methods, such as 11B qNMR, will find more common 
acceptance, allowing additional applications including structure elucidation, drug release and 
dissolution, stability testing, degradation studies, impurity identifications and counterfeit 
determination.  
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Some of the major limitations of the current 11B qNMR method study include the relatively 
high LOD value (720 ng/ml) which makes the method only clinically relevant to a portion of the 
patients population with high plasma concentration of BTZ (between 720 ng/ml and 1300 ng/mL). 
In addition, due to solubility limitations, peak resolution and spectra broadening observed with 
other solvents, the non-mannitol formulated BTZ’s 11B qNMR method development was not 
applicable to other bio-relevant solvents such as phosphate buffer solution, simulated gastric fluids 
and saline solutions. Follow up studies will investigate the suitability of a 11B qNMR method for 
the clinically available mannitol formulation of BTZ in these bio-relevant solvents. These future 
studies will also include the XRPD, 11B Solid State NMR (SSNMR) and the atomic force 
microscopy characterization of a modified, stimuli-responsive BTZ/Alg microparticles drug 
delivery system.  
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Figure 3-1. Empty Pz orbital 
Figure 3-2. Bortezomib an anti-cancer drug 
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Figure 3-4. BTZ 11B NMR spectra in selected screening solvents 
Figure 3-3. 1H NMR spectrum of Bortezomib 
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Figure 3-5. Linearity and calibration curve of 11B qNMR method for BTZ. Each data 
point is an average of three replicated experiments (n=3) 
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Figure 3-6. Specificity of 11B qNMR method for BTZ in the presence of Boric acid and PBA 
contaminants 
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Table 3-1. Accuracy of 11B qNMR method represented as percent mean recovery 
a Relative standard error 
 
 
 
 
 
 
 
                                                                                                                                                                                                     
 
  
Concentration (mg/ml) 
% Mean recovery ± %RSEa (n = 3) 
Intra-day Inter-day 
Within-day (Day 1) Day 2 Day 3 
3 100.22 ± 1.52 106.45 ± 1.04 106.56 ± 0.59 
6 95.68 ± 0.34 99.23 ± 0.43 103.00 ± 1.44 
11 102.56 ± 0.34 101.49 ± 0.73 103.57 ± 0.20 
16 97.13 ± 0.67 97.64 ± 0.15 99.72 ± 0.48 
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Table 3-2. Precision of 11B qNMR method represented as percent relative 
a Area Under Curve 
 b Relative Standard Error 
 
  
 
Concentration 
(mg/ml) 
Precision as %RSEb (n = 3) 
Intra-day Inter-day 
Within-day (Day 1) Day2 Day3 
AUCa (107) %RSEb AUCa (107) %RSEb AUCa (107) %RSEb 
3 0.49 
1.44 
0.52 
0.99 
0.51 
0.56 0.49 0.52 0.52 
0.47 0.50 0.51 
6 0.90 
0.35 
0.93 
0.42 
0.95 
1.4 0.90 0.93 0.97 
0.91 0.94 1.00 
11 1.75 
0.33 
1.74 
0.72 
1.77 
0.20 1.76 1.71 1.76 
1.74 1.76 1.78 
16 2.43 
0.68 
2.42 
0.15 
2.45 
0.48 2.37 2.42 2.47 
2.41 2.41 2.49 
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                      Figure 3-7. Accuracy and precision of 11B qNMR method   
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Table 3-3. Robustness of 11B qNMR 
a Area Under Curve 
b Relative Standard Error 
 
 
 
 
NMR parameter Robustness as %RSEb (n = 3) 
Average area under 
curve AUCa (107) 
%RSEb 
Temperature (°C) 35 1.31 0.29 
37 1.29 0.44 
39 1.25 1.16 
Pulse width (μs) 10.8 0.96 0.31 
11.0 1.01 0.27 
11.2 0.97 1.11 
Relaxation delay  (s) 0.2 0.86 0.61 
0.4 1.03 0.43 
0.6 1.06 0.14 
Proton decoupling Decoupled 1.04 0.64 
Coupled 0.98 0.49 
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Figure 3-8. 11B NMR spectra of BTZ at different temperatures 
Figure 3-9. 11B NMR spectra of BTZ with different pulse widths. 
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Figure 3-11. 11B NMR spectra of BTZ proton coupled and decoupled 
 
 
Figure 3-10. 11B NMR spectra of BTZ at different relaxation delays  
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Figure 3-12. Average particle size (A), surface charge density (B) and SEM image (C) of BTZ/Alg 
microparticle formulation. SEM image scale bar is 5 μm 
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Figure 3-13. FTIR spectra of BTZ, alginic acid sodium salt (Alg) and BTZ/Alg microparticles 
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Figure 3-14. Percent cumulative drug release (%w/w) profiles of BTZ from BTZ/Alg 
microparticles by direct 11B qNMR and dialysis methods. Actual drug concentration (mg/ml) 
released and best lines of fit are also represented. Each data point is an average of three 
replicated experiments (n=3) 
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Figure 3-15. Drug release (%w/w) profiles of BTZ from BTZ/Alg microparticles by direct 11B 
qNMR over time 
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Figure 3-16. Drug release (%w/w) profiles of BTZ from BTZ/Alg microparticles by dialysis 
methods 
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Table 3-4. : Kinetic models describing BTZ in vitro release profiles from BTZ/Alg 
microparticles by the direct 11B qNMR and dialysis methods 
                                              a Coefficient of determination, b Akaike information criterion 
 
  
Kinetic Model 
Direct 11B qNMR method  Indirect dialysis method 
Parameters R2a AICb  Parameters R
2a AICb 
Zero order k0 = 3.069 0.557 85.401  k0 = 2.860 0.686 77.136 
First order k1 = 1.902 0.834 52.412  k1 = 0.174 0.977 54.548 
Weibull α = 0.661 0.972 25.610  α = 19.082 0.994 33.008 
 β = 0.337    β =1.773   
Higuchi kH = 28.481 0.887 66.588  kH = 22.746 0.938 53.5188 
Korsmeyer-Peppas kKP = 77.581 0.969 26.120  kKP = 16.711 0.955 44.332 
 n = 0.098    n = 0.681   
Hixson–Crowell kHC = 0.100 0.980 55.600  kHC = 0.050 0.986 37.616 
Hopfenberg kHB = 0.040 0.821 41.382  kHB = 0.121 0.999 19.031 
 n = 4060.463    n  = 0.773   
Baker–Lonsdale  kBL = 0.062 0.980 39.661  kBL = 0.012 0.964 38.945 
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4.1 Introduction  
It has been estimated that the number of persons living with HIV worldwide in 2017 was 
36.7 million, out of which new infections are 44% higher in women. Women who acquired HIV-
1 through vaginal intercourse represent ∼60% of new infections in endemic regions, and there is 
no known cure for the condition 1. Many anti-retroviral (ARV) drugs have been clinically and FDA 
approved for the treatment of HIV, and a recent addition to this set of ARVs is a new class of drug. 
These new classes are known as entry inhibitors2. They prevent the entry of HIV R5 tropic strains 
into the host body by inhibiting the attachment of the HIV gp120 onto the human CCR5 co-
receptors. In other words, they are known as “anti CCR5 antagonists’, and the only FDA approved 
drug in this class is called Maraviroc (MVC). 
MVC is a small molecule (Figure 4-1)3 , and it is a white to yellowish or brownish powder 
with a chemical name of 4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-
triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide,and 
chemical formula C29H41F2N5O. It is a chemokine receptor antagonist that works by blocking the 
interaction between the HIV viral envelope complex (gp120 and gp41) and CCR5 by allosteric 
inhibition2. MVC is sparingly soluble in water (~ 0.0106 mg/mL), slightly soluble in some organic 
solvents, and highly soluble across physiological pH (1-7)2. 
MVC has been developed by Pfizer for oral administration only, and the absolute oral 
bioavailability of a 100 mg dose is 23%4.  About 65% of MVC is metabolized in the liver, and 
hepatotoxicity with allergic features including life-threatening events has been reported with the 
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use of MVC in clinical trials, and post marketing 2. Nonetheless, the FDA has approved the use of 
MVC with a label warning for possible hepatotoxic side effects.  
Vaginal microbicides are a potentially useful way to prevent the sexual transmission of 
HIV in order to bypass the metabolism of MVC in the liver and subsequently the hepatotoxic side 
effect MVC might have. MVC formulation intended for vaginal drug delivery of MVC has been 
investigated and results have been published in peer review journals. Malcolm et al. investigated 
the pharmacokinetics and efficacy of a vaginally administered MVC gel in rhesus macaques4, 
while in another study, Ball and Woodrow developed an electrospun solid dispersions of MVC for 
rapid intravaginal preexposure prophylaxis of HIV. They were able to successfully formulate 
MVC up to 28 wt% into electrospun solid dispersions made from either polyvinylpyrrolidone or 
poly(ethylene oxide) nanofibers or microfibers4. Furthermore, in 2018, Vincen et al. conducted a 
phase 1 trial to evaluate the safety and pharmacokinetics of pod-intravaginal rings (IVR) using a 
triple combination antiretroviral where MVC was a part of this combination5. They found that the 
pod-IVRs were safe and generally well tolerated in all treatment periods, and there were no 
concerning safety findings by participant report, examination with colposcopy, evaluation of 
vaginal microbiome (VMB), or histology from vaginal biopsy5. 
In this study, we developed and validated a 19F qNMR method that was effective in 
studying the real-time release of MVC from a spray-dried alginate microparticle formulation in a 
vaginal and seminal stimulated environment. Additionally, MVC real-time release kinetics were 
compared to the traditionally used dialysis method for drug release studies from nano or micro 
formulations. With the promising future that MVC could be ultimately formulated and licensed as 
a vaginal microbicide, this study may provide an additional tool for the analysis of and 
quantification of MVC and other fluorine containing pharmaceuticals in biologically stimulated 
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environments e.g. vaginal and seminal fluids, blood plasma, etc. This study may also contribute to 
the growing discussion on the use and effectiveness of the dialysis methods for studying drug 
release kinetics.  
4.2 Quantitative NMR spectroscopy  
Quantitative NMR spectroscopy techniques have demonstrated their extraordinary use as 
an analytical tool in pharmaceutical science. In contrast to other analytical techniques, NMR offers 
several advantages such as: (i) non-destructive and highly predictable character (ii) short 
measuring time (iii) easy sample preparation and handling (iv) no need for prior isolation or 
purification characterization of analyte mixtures.  
1H and 13C are the frequently utilized nuclei in pharmaceutical science to study by qNMR 
due to high accessibility of these atoms in natural and synthetics compounds.  However, the signal 
overlap, which originates when more than one carbon or proton have the same chemical 
environment, will significantly increase the spectral complexity and hamper qNMR analysis 
(Figure 4-2)6. Therefore, probing other NMR active nuclei such as 11B, 31P, and 15N has been 
recently done for quantification and characterization of therapeutic molecules7–9.  
There are several motivations of performing 19F qNMR to study the real time quantification 
of fluorinated drugs.  19F nucleus has a high gyromagnetic ratio (γ) of 40.052 MHz*T-1 , 
comparable to the gyromagnetic ratio of 1H 42.577 MHz*T-1 and enormously greater than 13C 
10.708 MHz*T-1. Moreover, 19F nucleus has 100% natural isotopic abundance, which is drastically 
higher than 13C (1.1%). Parallel to proton, 19F nucleus has nuclear spin of ½ which will yield a 
sharp signal and an easily interpreted spectra. 19F NMR offers the advantage of a wide range of 
chemical shift from about -300 to 400 ppm compared to proton which has a very narrow chemical 
shift range (0-15ppm). Additionally, 19F NMR may be more economical than 1H since there is no 
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need for deuterated solvents and the qNMR experiment can be obtained by using any solvent due 
to the absence of fluorine atoms in commonly used solvents10–12.   
Considering the downside of using 1H and 13C for quantitative analysis, in the current 
study, an investigation of a specific and direct method was developed and validated for a real-time 
solution-state quantitative fluorine nuclear magnetic resonance (19F qNMR) method for the 
analysis of fluorine containing therapeutic molecules.  
4.3 Materials and methods  
4.3.1 Reagents   
MVC was gifted by NIH, through the AIDS reagent program (USA). Addition MVC was 
purchased from ZhongShuo Pharmaceutical Technology Development Co.,Ltd. (Beijing, China). 
Alginic acid sodium salt (from brown algae, medium viscosity) were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Deionized water (DI water) was obtained through a Millipore 
Milli-Q water purification system (Millipore Corp., Danvers, MA). All other chemicals were of 
analytical grades and were used as obtained from suppliers.  
4.3.2 19F qNMR method development  
 In order to accurately estimate the amount of drug, the integrated peak area of fluorine in 
MVC was chosen as our interest. 19F qNMR spectroscopy was carried out on a Varian 400 MHz 
spectrometer (Palo Alto, CA, USA) with a Varian 2-channel probe. VnmrJ software (version 4.2A) 
was used for data acquisition and processing. The 19F spectra were acquired at frequency 376.147 
MHz. Preliminary analysis were performed such as an inversion recovery experiment to optimize 
the spin-lattice relaxation time, which was found to be ~0.2 s. Typically, most NMR active nuclei 
are fully relaxed after 5 times of T1, thus the relaxation delay was set to 1 s.  
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 The linewidth of the NMR signal is directly dependent on T2
* (the apparent spin-spin 
relaxation time). Large molecules such as polymers or proteins tend to have very small T2
* values, 
which gives rise to very broad peaks.  Therefore, it is expected that the integrated peak for a 
polymeric formulation of MVC will be very broad in comparison to free MVC (in solution) due 
to slow tumbling. Shimming was applied to each sample to maintain the same linewidth in each 
spectrum.  
For all 19F NMR experiments, the number of accumulated transients, and the pulse width 
were 256 and 45° (12.8μs), respectively, while the spectral width and FID acquisition time were 
86486.5 Hz and 0.758s. The total acquisition time for each spectrum was around eight minutes.   
The sample spinning frequency was 20 Hz. Experiments were performed in triplicate and average 
integrated peak area values were determined. C
6
H
5
CF
3 
(trifluoro-toluene) (in deuterated benzene) 
was used as 19F q-NMR external standard for referencing and its chemical shift (δ ~ -63.72 ppm) 
and peak resolution were assessed prior to any BTZ spectral acquisition. Typically, 650 μL of 
MVC samples were placed in a 5-mm outer diameter NMR tubes (Wilmad-LabGlass, Vineland, 
NJ, USA)  and 19F NMR experiments were conducted at 37ºC using a standard VT unit, unless 
specified otherwise. Baseline correction, phase adjustment, and integral calculations were carried 
out manually using MestReNova Lite (11.02.2, Escondido, CA, USA).  
4.4 preparation of biological fluids and MVC samples 
 In this study, simulated vaginal fluid (VFS pH 4.2) and simulated semen fluid (SFS, pH 
7.6) were utilized to conduct the drug release.  Each fluid was prepared individually according to 
a published method13. Owen et. al. reported that the volume of normal human vaginal fluid is 0.75 
mL, and the volume of human ejaculate is 3.4 ml. Therefore, VFS and SFS mixture (VSFS, pH 
7.6) at 1:3 ratio was prepared to mimic the scenario of human ejaculate presence13,14. 
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4.5 Method validation  
19F qNMR method was validated according to the International Conference on 
Harmonization (ICH) guidelines Q2(R1). Thus, several parameters (linearity, LOD, LOQ, 
specificity, precision, accuracy and robustness) were evaluated and the statistical variations within 
19F qNMR peak areas and/or MVC concentrations were presented as percent relative standard error 
(%RSE), as explained in chapter 2. 
In order to construct the standard curves of the method, six different concentrations of 
MVC (0.42- 15 mg/ml) were prepared by serial dilution of a standard (15 mg/ml) in VFS and 
VSFS respectively. 19F NMR peak’s area under the curve was then plotted in relation to MVC 
concentrations in VFS and VSFS. The intercept, slope, and coefficient of determination (R2) values 
were obtained by linear regression analysis.  
Specificity of 19F qNMR was tested using two different fluorinated compounds .To 
evaluate the accuracy of 19F qNMR, four (4) quality controls (QC) were used with concentration 
(15, 10, 7, and 5 mg/ml). Robustness was verified by varying two parameters: pulse width (µs), 
and relaxation delay (s).  
4.6 Preparation of alginate microparticles  
Alginate microparticle formulation of MVC was prepared according to a published 
method, with minor modifications15. Accordingly, alginic acid sodium salt and MVC were added 
to 150 ml of a solution of 15% VFS and VSFS (in DI water, pH 7.2) at a ratio of 4:1. The mixture 
was stirred at room temperature (25 °C) until both the drug and polymer were completely 
dissolved. The solution was then spray-dried on a Buchi Mini Spray Dryer, Model 290 (Buchi 
Laboratoriums Technik AG, Flawil, Switzerland). The spray dryer inlet temperature was T = 120 
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°C, the outlet temperature at the collector was 32°C, the aspirator was maintained at 85%, the 
pump rate was 10%, and the nozzle cleaner was set at 7. Dried microparticle powder was collected 
from the instrument and stored at 4 °C for further analysis. 
4.7 Physicochemical characterization  
4.7.1 Size and surface charge  
MVC microparticle size and zeta potential (ζ-potential) measurements were conducted by 
dynamic light scattering (DLS) on a Malvern instrument 3600 Zetasizer Nano (Worcestershire, 
UK). Essentially, 1 mL of sample suspension (in DI water) was prepared in a disposable size 
measurement cuvette and briefly sonicated (20 s) using an ice bath sonication (Qsonica LLC, 
Newtown, CT, USA). Surface charge density (ζ-potential) measurements were conducted by 
transferring a sonicated sample into DTS 1070 Zetasizer disposable folded capillary cells (Malvern 
Instruments, Northampton, MA, USA). Size and ζ-potential cuvettes were then placed in the cell 
area one after another, and experiments were performed at 25 °C on the Zetasizer instrument. Data 
acquisition and analysis were conducted using Zetasizer software (version 6.01, Worcestershire, 
UK). Preceding any DLS measurements, the instrument was calibrated using nanosphere size 
standards (60.0 ± 4 nm) and ζ-potential transfer standards (−42.0 ± 4.2 mV) obtained from Malvern 
Instruments (Northampton, MA, USA). 
4.7.2 Fourier transform infrared spectroscopy (FTIR) 
The IR spectra were acquired on Nicolet IS10 FTIR instrument (Thermo Fisher Scientific, 
Madison, WI, USA) equipped with a Zinc selenide (ZnSe) crystal. The instrument was used in the 
Attenuated Total Reflectance (ATR) mode. A resolution of 4 cm-1 and a sample scan of 228 were 
fixed as basic acquisition parameters. Transmittance IR spectra were acquired between 4000 and 
650 cm-1. For better spectral resolution, all samples were allowed to make intimate contact with 
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the ATR ZnSe crystal’s surface by pressing them with a built-in pressure clamp. FTIR spectra 
were collected and analyzed with OMNIC Specta Software (Thermo Fisher Scientific, Madison, 
WI, USA). Typically, the average IR spectrum acquisition time was 6 minutes.   
4.7.3 Scanning electron microscopy (SEM) 
To analyze MVC microparticles’ morphology, SEM imaging was conducted on a field-
emission environmental SEM Philips XL30 instrument (Hillsboro, OR, USA). Consequently, a 
small amount of dried microparticles was sprayed onto a stub covered with an adhesive conductive 
carbon tab. Excess material was removed using a paintbrush, and the sample was sputter-coated 
with a thin layer of gold. Images were acquired at an accelerating voltage of 5 kV. 
4.7.5 Drug release kinetics 
In this study, MVC real-time release from an alginate microparticle formulation vaginal 
fluid stimulant (VFS) and a mixture of vaginal fluid stimulant and seminal fluid stimulant (VSFS) 
was assessed by 19F qNMR, and the release profile was compared to a control condition performed 
in a dialysis bag. Concisely, a dispersion of alginate microparticles (10 mg/mL) was prepared in 
VFS and VSFS and immediately transferred into an NMR tube. Time dependent MVC release (% 
drug release) was further determined by acquiring 50 19F NMR spectra in 5 hours release at 37 °C. 
In a separate experiment, an alginate microparticle sample was prepared at 10 mg/mL in VFS and 
VSFS and immediately placed into a dialysis bag (Spectra/Por Float-A-Lyzer G2, MWCO 8–10 
kDa; Spectrum Laboratories, Inc., Rancho Dominguez, CA, USA). The dialysis tube was further 
immersed into a VFS and VSFS bath (15 mL), and the mixture was placed in a thermostatic water 
bath at 37 °C, under shaking at 60 rpm. Sample aliquots (1 mL) were collected at predetermined 
time points (5, 10, 20, 40, 80, 160, 320, and 640 min) from the receiving compartment, and MVC 
concentration was determined by 19F qNMR. The sink condition was maintained by adding 1 ml 
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of free VFS and VSFS solution in the outer receiving dialysis compartment following each sample 
collection. All experiments were conducted in triplicate (n = 3), and the time dependent MVC 
release (% drug release) curve was determined from the calibration curve, by processing the 19F 
qNMR spectra and getting the area under the curve (AUC). Unlike the dialysis method, in the 
direct NMR release method, the drug molecules released from the microparticles formulation do 
not have to diffuse through a separating membrane before they can be collected and analyzed by 
qNMR. Thus, drug molecules released in the NMR tube’s method are directly analyzed as soon as 
they are released from the alginate microparticles. 
4.8 Results and discussion  
4.8.1 19F-qNMR method development and validation  
The 19F qNMR method was developed and validated based on ICH Q2(R1) guidelines. The 
method was linear in the concentration range tested of MVC in VFS and VSFS (0.43-15 mg/ml or 
0.83-29.2 mM) (Figure4-3&4). The linear equations are y = 5595.1x - 231.98(in VFS), and y = 
4421.7x - 329.74 (in VSFS). The coefficient of determination (R2) in VFS and VSFS are 0.9978 
and 0.9995 respectively. Although the LOD and LOQ values, (LOD=0.97mg/ml, 
LOQ=2.93mg/ml), obtained by 19F NMR spectroscopy are substantially higher than the values 
reported using UV spectroscopy (0.1028 and 0.315μg/ml)16, several qNMR methods have been 
reported in the field of pharmaceutical research and the LOD and LOQ obtained are consistent 
with the range of 19F qNMR method7,8. Comparing qNMR method sensitivity with other analytical 
methods such as UV and HPLC, qNMR method has lower sensitivity. It has been found that the 
LOD and LOQ of 1H qNMR, 31P qNMR and 11B qNMR were higher compared to their respective 
method in HPLC7,8.  
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The specificity of the 19F qNMR method of MVC was tested. The peaks of two fluorinate 
compounds did not interfere with the peak of MVC, and it could be accurately quantified (Figure4-
5).  The 19F qNMR method of MVC was accurate with all percent mean recovery values within 
100 ± 10% and %RSE values <2%, for both intra-day and inter-day recovery studies in VFS and 
VSFS (Table 4-1&2). The method was also precise and %RSE values for intra-day and inter-day 
precision analysis were <2% for all four QC samples tested in both VFS and VSFS (Table 4-3&4). 
These results were consistent with ICH guidelines and confirmed the closeness of agreement 
(reproducibility) between the AUC values of 19F qNMR spectra for each QC sample. 
The 19F qNMR method’s robustness was verified by varying three different NMR 
instrumental parameters. Table 4-5 shows that the method was robust and not affected by changing 
any parameter as all %RSE were < 2%. 
4.8.2 Physicochemical characterization 
Following the preparation of spray-dried MVC/Alg microparticles, average particle size 
and ζ-potential measurements were conducted on the Zetasizer Nano instrument. Figures 4-6 A 
and B summarize the size and surface charge density analysis of the microparticle formulation. 
Although it is routinely used for nanomaterial characterization, the Zetasizer Nano instrument is 
suitable for microparticle surface charge density and size measurements (≤10 μm)17. The 
MVC/Alg microparticle average particle size was 2.522 ± 0.19 μm, and the polydispersity index 
(PDI) was 0.559. The microparticles were negatively charged, and the average ζ-potential was 
−61.3.1 ± 2.2 mV. The strong negative charge is likely due to the carboxylate group of alginic acid 
sodium salt, which is expected to be fully deprotonated (ionized) in neutral pH conditions (alginic 
acid’s pKa ∼ 3.4–4.4). The SEM image revealed that individual BTZ/Alg microparticles are 
spherical in shape with varying size and morphology. Nevertheless, the average particle size was 
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consistent with the Zetasizer measurements. In FT-IR spectra (Figure 4-7), all the bands observed 
in MVC/Alg microparticle were consistent with the bands observed in Alg and MVC IR spectra.  
4.8.3 MVC in vitro drug release 
The developed and validated 19F qNMR method was applied for the real-time release study 
and quantification of MVC from alginate microparticles (MP) fabricated using spay drying 
technique. In the case of the direct 19F qNMR measurements in the NMR tube, a significant burst 
release of MVC was observed in both VFS and VSFS (Figures 4-8&9). In addition, an equilibrium 
in the MVC profile was achieved, where ~100% of the drug was released in about 20 minutes.  
In order to achieve a more slow and steady release of MVC from our MP formulation, a 
cross-linking process by ionic interaction with divalent cations, such as Ca2+, Ba2+, and Sr2+ can 
be performed. The cross-linking process is believed to arise as a result of the linkage between these 
divalent cations and guluronate regions on the alginate backbone18.  
Alternatively, a pH sensitive polymer can be explored in the development of MVC 
microparticles formulation. A pH sensitive polymer like Eudragit S-100 can be used as a model 
pH sensitive polymer for the encapsulation of MVC. The rationale is that Eudragit which is soluble 
above pH 7, and at low pH values (~4.2-5) MVC would release slowly, while at neutral pH (~7.6), 
there would be a faster release of MVC from Eudragit MPs19.  
4.9 Conclusion 
In this study, 19F qNMR method was developed and validated according to the ICH Q2R(1) 
guidelines. The method was linear, specific for MVC, precise, accurate and robust. The 19F qNMR 
method was applied to study the real time quantification of MVC drug release from an alginate 
microparticle formulation. Based on the results obtained by 19F NMR, MVC was released 
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completely within 20 minutes in both VFS and VSFS. Future work will include controlling the 
release profile of MVC from microparticle using cross linking process and a pH sensitive polymer.  
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Figure 4-1. Maraviroc  
Figure 4-2. Proton NMR spectra of Maraviroc  
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Figure 4-3. Calibration curve of Maraviroc in VFS  
Figure 4-4. Calibration curve for Maraviroc in VSFS 
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Figure 4-5. Specificity of 19F qNMR method in presence of other possible contaminants  
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Table 4-1. Accuracy of 19F qNMR method in VFS represented as percent mean recovery    
 
 
 
 
  
 
  
 
   
 
   
 
   
 
   
Table 4-2. Accuracy of 19F qNMR method in VSFS represented as percent mean recovery    
 
 
 
MVC Concentration 
(mg/ml) 
% Mean recovery ± %RSEa (n = 3) 
Intra-day Inter-day 
Within-day (Day 1) Day 2 Day 3 
15 100.45±0.9 97.30±0.88 95.40±0.45 
10 98.37±0.69 99.14±0.31 74.93±0.31 
7 94.70±0.63 94.56±0.26 92.12±1.54 
5 98.76±0.73 99.09±0.91 99.53±0.10 
MVC Concentration 
(mg/ml) 
% Mean recovery ± %RSEa (n = 3) 
Intra-day Inter-day 
Within-day (Day 1) Day 2 Day 3 
15 ±0.9 97.30±0.88 95.40±0.45 
10 98.37±0.69 99.14±0.31 74.93±0.31 
7 94.70±0.63 94.56±0.26 92.12±1.54 
5 98.76±0.73 99.09±0.91 99.53±0.10 
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Table 4-3. Precision of the 19F qNMR method in VFS represented as percent relative standard 
error  
   
        
  Intra-day Inter-day 
 Concentration 
     (mg/ml) 
 Within-day day1 day2 day3 
peak 
area*10^5 
%RSE 
peak 
area*10^5 
%RSE 
peak 
area*10^5 
%RSE 
peak 
area*10^5 
%RSE 
15 
0.8281 
0.9 
0.8281 
0.9 
0.8291 
0.9 
0.7906 
0.9 0.8503 0.8503 0.8072 0.8023 
0.8464 0.8464 0.8065 0.8022 
10 
0.5513 
0.7 
0.5513 
0.7 
0.5518 
0.3 
0.4204 
0.3 0.5585 0.5585 0.5496 0.4146 
0.5428 0.5428 0.5556 0.4158 
7 
0.3715 
0.66 
0.3715 
0.66 
0.3687 
0.2 
0.3602 
0.2 0.3636 0.3636 0.366 0.3679 
0.3705 0.3705 0.3694 0.3472 
5 
0.27 
0.73 
0.27 
0.73 
0.2799 
0.9 
0.2058 
0.9 0.2749 0.2749 0.2732 0.2059 
0.2769 0.2769 0.2715 0.2067 
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Table 4-4. Precision of the 19F qNMR method in VSFS represented as percent relative standard 
error  
 
 
 
 
 
 
 
 
 
  
  Intra-day Inter-day 
 Concentration 
     (mg/ml) 
 Within-day day1 day2 day3 
peak 
area*10^5 
%RSE 
peak 
area*10^5 
%RSE 
peak 
area*10^5 
%RSE 
peak 
area*10^5 
%RSE 
15 
0.61 
0.01 
0.61 
0.01 
0.62 
0.0003 
0.62 
4.61E-05 0.58 0.58 0.63 0.62 
0.62 0.62 0.62 0.62 
10 
0.45 
0.003 
0.45 
0.003 
0.45 
0.0072 
0.45 
0.0005 0.44 0.44 0.45 0.45 
0.45 0.45 0.44 0.45 
7 
0.29 
0.01 
0.29 
0.01 
0.29 
0.001 
0.29 
0.004 0.30 0.30 0.29 0.30 
0.29 0.29 0.29 0.29 
5 
0.21 
0.008 
0.21 
0.008 
0.20 
0.015 
0.20 
0.001 0.20 0.20 0.20 0.20 
0.20 0.20 0.21 0.20 
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Table 4-5. Robustness of 19F qNMR in VFS  
 
 
 
 
 
 
 
 
 
 
 
NMR parameter 
 
Average area under 
curve AUCa (105) 
%RSEb 
 
Pulse width (μs) 12.4  
0.36 0.13 
12.8  
0.36 0.03 
13.2  
0.36 0.02 
Relaxation delay  (s) 
0.8  
0.86 0.01 
1  
0.36 0.02 
1.4  
0.37 0.09 
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Table 4-6.  Robustness of 19F qNMR in VSFS 
 
NMR parameter 
 
Average area under 
curve AUCa (105) 
%RSEb 
 
Pulse width (μs) 12.4  
0.36 0.13 
12.8  
0.36 0.03 
13.2  
0.36 0.02 
Relaxation delay  (s) 
0.8  
0.86 0.01 
1  
0.36 0.02 
1.4  
0.37 0.09 
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Figure 4-6. Average particle size diameter (A), surface charge density (B), and SEM image of 
MVC/Alg micorparicle formulation.  
 
 
  
Figure 4-7. FT-IR Spectra of (A) maraviroc, (B) alginate, and (C)alginate 
microparticles 
A 
B 
C 
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4-8.  
 
Figure 4-8. Percent cumulative drug release profiles of MVC from MVC/Alg 
microparticles in VFS 
 
Figure 4-9. Percent cumulative drug release profiles of MVC from MVC/Alg 
microparticles in VSFS 
114 
 
 
References 
(1)  Owusu, E. D. A.; Cofie, N. S.; Nai, E. A.; Klipstein-Grobusch, K.; Brown, C. A.; Mens, P. 
F.; Grobusch, M. P. Malaria, Sickle Cell Disease, HIV, and Co-Trimoxazole Prophylaxis: 
An Observational Study. Int. J. Infect. Dis. 2018, 69, 29–34. 
https://doi.org/10.1016/j.ijid.2018.01.031. 
(2)  Lieberman-Blum, S. S.; Fung, H. B.; Bandres, J. C. Maraviroc: A CCR5-Receptor 
Antagonist for the Treatment of HIV-1 Infection. Clin. Ther. 2008, 30 (7), 1228–1250. 
https://doi.org/10.1016/S0149-2918(08)80048-3. 
(3)  maraviroc https://en.wikipedia.org/wiki/Maraviroc. 
(4)  Ball, C.; Woodrow, K. Electrospun Solid Dispersions of Maraviroc for Rapid Intravaginal 
Preexposure Prophylaxis of HIV. Antimicrob. Agents Chemother. 2014, 58 (8), 4855–
4865. https://doi.org/10.1128/AAC.02564-14. 
(5)  Vincent, K. L.; Moss, J. A.; Marzinke, M. A.; Hendrix, C. W.; Anton, P. A.; Pyles, R. B.; 
Guthrie, K. M.; Dawson, L.; Olive, T. J.; Butkyavichene, I.; et al. Safety and 
Pharmacokinetics of Single, Dual, and Triple Antiretroviral Drug Formulations Delivered 
by Pod-Intravaginal Rings Designed for HIV-1 Prevention: A Phase I Trial. PLOS Med. 
2018, 15 (9), e1002655. https://doi.org/10.1371/journal.pmed.1002655. 
(6)  Tseng, E.; Fate, G. D.; Walker, G. S.; Goosen, T. C.; Obach, R. S. Biosynthesis and 
Identification of Metabolites of Maraviroc and Their Use in Experiments to Delineate the 
Relative Contributions of Cytochrome P4503A4 versus 3A5. Drug Metab. Dispos. 2018, 
46 (5), 493–502. https://doi.org/10.1124/dmd.117.079855. 
(7)  Coulibaly, F. S.; Alnafisah, A. S.; Oyler, N. A.; Youan, B.-B. C. Direct and Real-Time 
115 
 
Quantification Of Bortezomib Release From Alginate Microparticles Using Boron ( 11 B) 
Nuclear Magnetic Resonance Spectroscopy. Mol. Pharm. 2019, 16 (3), 967–977. 
https://doi.org/10.1021/acs.molpharmaceut.8b00873. 
(8)  Agrahari, V.; Meng, J.; Purohit, S. S.; Oyler, N. A.; Youan, B. B. C. Real-Time Analysis 
of Tenofovir Release Kinetics Using Quantitative Phosphorus (31P) Nuclear Magnetic 
Resonance Spectroscopy. J. Pharm. Sci. 2017, 106 (10), 3005–3015. 
https://doi.org/10.1016/j.xphs.2017.03.043. 
(9)  Levy, G. C.; Pehk, T.; Srinivasan, P. R. Quantitative15N NMR Spectroscopy. Org. Magn. 
Reson. 1980, 14 (2), 129–132. https://doi.org/10.1002/mrc.1270140210. 
(10)  Wang, J.; Sánchez-Roselló, M.; Aceña, J. L.; del Pozo, C.; Sorochinsky, A. E.; Fustero, 
S.; Soloshonok, V. A.; Liu, H. Fluorine in Pharmaceutical Industry: Fluorine-Containing 
Drugs Introduced to the Market in the Last Decade (2001–2011). Chem. Rev. 2014, 114 
(4), 2432–2506. https://doi.org/10.1021/cr4002879. 
(11)  Okaru, A. O.; Brunner, T. S.; Ackermann, S. M.; Kuballa, T.; Walch, S. G.; Kohl-
Himmelseher, M.; Lachenmeier, D. W. Application of 19F NMR Spectroscopy for 
Content Determination of Fluorinated Pharmaceuticals. J. Anal. Methods Chem. 2017, 7. 
https://doi.org/10.1155/2017/9206297. 
(12)  Ando, S.; Harris, R. K.; Scheler, U. Fluorine-19 NMR of Solids Containing Both Fluorine 
and Hydrogen. In Encyclopedia of Magnetic Resonance; John Wiley & Sons, Ltd: 
Chichester, UK, 2007; Vol. 9, pp 531–550. 
https://doi.org/10.1002/9780470034590.emrstm0171. 
(13)  Owen, D. H.; Katz, D. F. A Vaginal Fluid Simulant. Contraception 1999, 59 (2), 91–95. 
https://doi.org/10.1016/S0010-7824(99)00010-4. 
116 
 
(14)  Owen, D. H. A Review of the Physical and Chemical Properties of Human Semen and the 
Formulation of a Semen Simulant. J. Androl. 2005, 26 (4), 459–469. 
https://doi.org/10.2164/jandrol.04104. 
(15)  Meng, J.; Agrahari, V.; Ezoulin, M. J.; Purohit, S. S.; Zhang, T.; Molteni, A.; Dim, D.; 
Oyler, N. A.; Youan, B.-B. C. Spray-Dried Thiolated Chitosan-Coated Sodium Alginate 
Multilayer Microparticles for Vaginal HIV Microbicide Delivery. AAPS J. 2017, 19 (3), 
692–702. https://doi.org/10.1208/s12248-016-0007-y. 
(16)  Notari, S.; Tommasi, C.; Nicastri, E.; Bellagamba, R.; Tempestilli, M.; Pucillo, L. P.; 
Narciso, P.; Ascenzi, P. Simultaneous Determination of Maraviroc and Raltegravir in 
Human Plasma by HPLC-UV. IUBMB Life 2009, 61 (4), 470–475. 
https://doi.org/10.1002/iub.181. 
(17)  Islam, P.; Water, J.; Bohr, A.; Rantanen, J. Chitosan-Based Nano-Embedded 
Microparticles: Impact of Nanogel Composition on Physicochemical Properties. 
Pharmaceutics 2016, 9 (4), 1. https://doi.org/10.3390/pharmaceutics9010001. 
(18)  Szekalska, M.; Sosnowska, K.; Czajkowska-Kośnik, A.; Winnicka, K. Calcium Chloride 
Modified Alginate Microparticles Formulated by the Spray Drying Process: A Strategy to 
Prolong the Release of Freely Soluble Drugs. Materials (Basel). 2018, 11 (9), 1522. 
https://doi.org/10.3390/ma11091522. 
(19)  Zhang, C.; Zhang, T.; Oyler, N. A.; Youan, B. B. C. Direct and Real-Time Quantification 
of Tenofovir Release from Ph-Sensitive Microparticles into Simulated Biological Fluids 
Using1H Nuclear Magnetic Resonance. J. Pharm. Sci. 2014, 103 (4), 1170–1177. 
https://doi.org/10.1002/jps.23886. 
 
117 
 
 
 
 
 5.1 Introduction 
  The Human immunodeficiency virus (HIV) is one of the global epidemics that afflicts 
human civilization and concerns people worldwide. It is responsible for the acquired immune 
deficiency syndrome (AIDS). The first case was discovered in United States in 19811 . Scientists 
believed that the monkey was the original source of HIV/AIDS in humans. They discovered that 
the chimpanzees in West Africa carried the same type of HIV virus known as simian 
immunodeficiency virus (SIV)2,3. Moreover, they found that SIV is closely related to HIV4. The 
virus was transferred to humans when hunters were exposed to infected blood. The lack of 
knowledge about this virus contributes to increases in HIV/AIDS.  The HIV virus attacks the 
immune system in the human body, mainly CD4 cells (T cells), which is responsible for defending 
against diseases. Untreated HIV will result in a severe reduction of the CD4 cells; hence it will 
make the body more likely to get other infections. Ultimately, HIV will destroy all CD4 cells 
resulting in a very weak body. At that stage, it is a sign that the person has AIDS, which is the last 
stage of HIV infection. In the mid-1990s, people who had HIV virus reached the AIDS stage 
rapidly. However, with the medicine progression, HIV can be controlled but not effectively treated 
by using a medicine called antiretroviral therapy (ART). Taking the medicine regularly delays the 
advancement of the virus and reduces the possibility of transmitting the virus to others.   
  When HIV occurs, the virus targets the CD4 cells. There are several phases for HIV viral 
entry as shown in (Figure  5-1)5. The first step of viral entry is binding of the envelope glycoprotein 
(gp120), which is located on the surface of HIV envelope, to its primary receptor CD4, a 
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glycoprotein found on the surface of immune cells. As a result of this binding, the second step of 
viral entry will take place by doing some conformational rearrangements and CD4 will build a 
bridge sheet with the virus. The third step of viral entry is binding to c-c chemokine receptor type 
5 (known as CCR-5). Then the fourth step involves the movement of virus particles to a position 
where a membrane penetration can occur. The fifth and the final step of the viral entry is membrane 
fusion.  
 HIV has heavily glycosylated surface glycoproteins (HIV gp120/HIV gp41). It is reported 
that approximately half of HIV envelope glycoprotein (HIV gp120) molecular mass is composed 
of carbohydrates, which are mostly mannose oligo-mannose glycans (Man5-9) 
6–9. HIV gp120 high 
glycan content is believed to promote host cell recognition, immune evasion, enhanced infectivity 
and resistance 10,11. HIV prevention strategies targeting glycans on HIV viral envelope and 
transmembrane glycoproteins (HIV gp120/ HIV gp41) have emerged as potentially viable viral 
entry inhibition approaches 12. In general, natural lectins extracted from plants, animals or bacteria 
have been used to target specific HIV gp120 glycan structures13. Binding of natural lectins to 
oligomannoglycans, covering the underlying amino acids in HIV gp120, could potentially hinder 
a proper interaction between the virus and its target cells or affect HIV gp120/ HIV gp41 post-
binding conformational alterations, which are critical for viral entry and/or infectivity 13. Among 
others, Griffithsin, an algae-derived lectin, and BanLec, a fruit lectin extracted from banana, have 
shown  remarkable anti-HIV activity 14  Furthermore, concanavalin A (Con A) immobilized 
polystyrene nanospheres formulations were shown to strongly bind to HIV gp120 and significantly 
reduced HIV-1 viral infectivity 15,16.  
  Due to limitations such as mitogenecity, solubility, resistance and cost of manufacturing 
associated with natural lectins used as anti-HIV agents, synthetic lectins are increasingly being 
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explored as alternative lectin-based HIV entry inhibitors.  Synthetic lectins, which are essentially 
composed of boronic acids, are cheaper to synthesize, manufacture, purify and commercialize17. 
Conceptually, synthetic lectins exert their antiviral activity taking advantage of the boronic acids 
functional group’s ability to form stable boronic esters with diols, such as those found in 
carbohydrates on HIV gp12018. The formation of stable boronic esters with HIV surface glycans 
might lead to HIV “virions capture” which might prevent viral entry and replication16. 
Benzoboroxole functionalized polymers, proposed by Mahalingam et al.17, were shown to 
significantly inhibit HIV infectivity (EC50 = 15 nM at 75 mol % BzB). Furthermore, 
monophenylboronic acids-based carbohydrate binders were synthesized and tested by Trippier et 
al. for their antiviral potential19. This study was followed up by the synthesis and analysis of a 
series of bisphenylboronic acids-based carbohydrate binders20. Although the mono and 
bisphenylboronic acids did not demonstrate any pronounced antiviral activities, these compounds 
did show low cytotoxicity in human T-lymphocyte cells culture. The lack of strong HIV gp120 
binding activity demonstrated by mono and bisphenylboronic acids was attributed to their small 
size and the lack of multivalency in those compounds. By addressing the multivalency and size 
limitation observed with mono and bisphenylboronic acids, we hypothesized that a phenylboronic 
acid (PBA) closomer nanoscaffold could strongly bind to HIV gp120. Closomers are derivative of 
dodecahydroxy-closo-dodecaborate ([𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝑂𝐻12]
2−) and have gained increasing attention 
in drug design and delivery21,22. taking advantage of the so-called “vertex differentiation” 
approaches, closomers virtually allow 12 different cargos attachment to the boron cage23. This may 
open new avenues for combination therapies24–26 and the development of novel theranostic 
applications where targeting ligand(s), therapeutic agent(s) and imaging agent(s) are often 
combined in a single nanocarrier11,27,28. Closomers have demonstrated very low toxicity in animal 
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studies27,29 suggesting that these scaffolds might represent a safe and effective drug delivery 
alternative to polymeric nanocarriers30. Furthermore, the ability to synthesize uniform closomer 
nanoscaffolds could potentially address the size, composition and structural heterogeneity 
generally observed in polymeric nanocarriers31.  
5.2 General research approach 
The objectives of this project are: 
A Phenylboronic Acid (PBA)-immobilized closomer nanocomplex could be used as an entry 
inhibitor by capturing HIV virions, thus preventing HIV sexual transmission. Phenyl boronic Acid 
(PBA) are known to form boronic acid in the presence of cis-diol, like the one found in HIV-gp120 
glycoproteins. To test this hypothesis: 
1.  A derivative of Phynel boronic acid (PBA) was synthesized  
2. 11B NMR spectroscopy as well as FT-IR spectroscopy were utilized as a characterization 
tool for the reaction progression.  
3. Biological studies will be performed to test the binding affinity between HIV/GP21 and 
the derivative of PBA.  
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5.3 Experimental methods 
5.3.1 Chemicals and reagents. 
Cesium dodecahydrododecaborate 𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝐻12] was obtained from Strem 
Chemicals (Newburyport, MA, USA). Hydrogen peroxide solution (H2O2) 30 % (w/w) in water; 
Tetrabutylammonium hydroxide (TBA) solution ~40% in water; 4-(Bromomethyl)phenylboronic 
acid (PBA), N,N-Diisopropylethylamine and Acetonitrile are purchased from Sigma-Aldrich (St. 
Louis, MO, USA). Dowex® 50 WX8-200 cation-exchange resin was purchased from GFS 
Chemicals. CM5 sensor chips; HBS-EP buffer [0.01 M HEPES pH 7.40, 15 M NaCl, 3 mM EDTA, 
0.005% (v/v), surfactant P20); amine coupling kit [1-Ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC), 750 mg N-Hydroxysuccinimide (NHS), 115 mg 1.0 M 
Ethanolamine-HCl pH 8.5]; immobilization buffer [10 mM sodium acetate pH 4.0] and 
regeneration solutions [50 mM NaOH] were purchased from GE Healthcare Bio-Sciences 
(Pittsburgh, PA, USA). Human vaginal keratinocytes cell line (VK2/E6E7, ATCC Number CRL-
2616) and Murine macrophage [RAW 264.7 (TIB-71)] were obtained from the American Type 
Culture Collection (Manassas, VA, USA). Resazurin sodium salt, neutral red (NR), sodium 
nitroprusside dehydrate (SNP), Dulbecco's Phosphate-Buffered Saline (DPBS), acetic acid, ethyl 
alcohol (ethanol) pure 200 proof ACS reagent (≥99.5%), Triton™ X-100 and lipopolysaccharides 
(LPS). Dulbecco's Modified Eagle Medium (DMEM) and keratinocyte serum-free medium (1X) 
(K-SFM) were purchased from Thermo Fisher Scientific (Waltham, MA, USA). 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt 
(MTS) was purchased from Promega Corporation (Madison, WI, USA). Human 
Immunodeficiency Virus type 1 recombinant envelope glycoprotein (HIV-1 rgp120) were 
obtained from NIH AIDS Reagent Program (Germantown, MD, USA).  
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5.3.2 Experimental section: 
Synthetic scheme of PBA closomer nanoscaffold 
 Figure 5-2 shows the overall synthetic scheme. The reaction is comoposed of two steps, 
namely hydroxylation and etherfication respectively.   
Cage hydroxylation  
       PBA closomer was synthesized following the method of Hawthorne et al32. Briefly, 
𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝑂𝐻12] was synthesized by dissolving 2g of 𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝐻12] in 15 ml of 
H2O2 and the mixture was left to reflux at 110 ºC. 
11B NMR and IR spectroscopy assessed reaction 
progress. Two (2) ml of H2O2 was added to the reaction mixture every 3 days until reaction 
completion which is indicated by the complete disappearance of 𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝐻12] singlet at -
17.7 ppm and the appearance of a new singlet around -20.3 ppm, characteristic of 
𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝑂𝐻12] (Figure 5-3) 
   𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝑂𝐻12] is not soluble in organic solvents such as acetonitrile and 
dichloromethane due to Cs+ counter ion . Therefore, to enhance the solubility of the closomer in 
organic solvents, Cs was replaced with more hydrophobic counter ions such as TBA (tetra-n-
butylammonium). Cationic exchange chromatography was used to convert 𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝑂𝐻12] 
to 𝑇𝐵𝐴2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝑂𝐻12].(Figure 5-4) shows the cationic exchange chromatography setup.  
Cage etherification  
      As shown in (Figure 5-5), the ether linked closomer was synthesized by following the 
method of Hawthorne et al32.  PBA closomer was synthesized by dissolving 0.5g of 
𝑇𝐵𝐴2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝑂𝐻12] in 25ml of acetonitrile. 2 ml of N,N-diisopropylethylamine and bromo 
phenylboronic acid were added. The mixture was left to reflux at 150 ºC for 7 days. Reaction 
progress was evaluated by 11B NMR and FTIR spectroscopy. 
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5.4 Structure Characterization  
11B NMR spectroscopy was carried out on a Varian 400 MHz spectrometer (Palo Alto, CA, 
USA) with a Varian 2-channel probe. VnmrJ software (version 4.2A) was used for data acquisition 
and processing. Wilmad® quartz NMR tubes (600 MHz, diam. 5 mm, L7 in, Sigma-Aldrich, St. 
Louis, MO, USA) were used for spectral acquisition in order to eliminate the contribution of 
borosilicate glass in the spectrum. An inversion recovery experiment was performed to optimize 
the relaxation delay (T1), which was found to be 0.4s. Shimming was applied to each sample to 
maintain the same linewidth in each spectrum. The number of scans and the pulse width were 512 
and 90° (11μs), respectively. The spinning frequency was 20 Hz.  BF3.OEt2 (15% in CDCl3) was 
used as a 11B q-NMR external standard and its chemical shift (δ ~ 0 ppm). Typically, 650 μL of a 
sample are placed in the quartz NMR tubes. Baseline correction and phase adjustment were carried 
out manually using MestReNova Lite (11.02.2, Escondido, CA, USA).  
     IR spectra were acquired by the Nicolet IS10 FTIR instrument (Thermo Fisher 
Scientific, Madison, WI, USA) equipped with a Zinc selenide (ZnSe) crystal. The instrument was 
used in the Attenuated Total Reflectance (ATR) mode. A resolution of 4 cm-1 and a sample scan 
of 228 were fixed as basic acquisition parameters. Transmittance IR spectra were acquired between 
4000 and 650 cm-1. For better spectral resolution, all samples were allowed to make intimate 
contact with the ATR ZnSe crystal’s surface by pressing them with a built-in pressure clamp. FTIR 
spectra were collected and analyzed with OMNIC Specta Software (Thermo Fisher Scientific, 
Madison, WI, USA). Typically, the average IR spectrum acquisition time was 6 minutes.   
5.5 Results and discussion  
      To characterize the PBA closomer, 11 B NMR spectroscopy as well as FT-IR were utilized. 
(Figure 5-6) shows 11 B NMR spectra of the reaction progression. The singlet peak at -17.7 ppm 
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in day zero spectrum corresponds to the starting material 𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝐻12]. As the reaction 
progressed, the peak of the starting material began to decrease on day two, seven, and ten. 
Simultaneously, a new peak at -20.3 started to appear which is the product 𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝑂𝐻12]. 
By the end of this reaction, the peak at -17.7 completely disappeared and only a singlet peak at -
20.3 ppm was present on day fifteen(Figure 5-6). 
      Moreover, the reaction was monitored by FT-IR as it confirmed the completion of the 
reaction as well.  The absorption spectra are shown in (Figure 5-7) for the reaction progression. 
The FTIR spectra collected for the reaction on day one, ten, and fifteen respectively. The 
appearance and growth of a band at 3250 cm-1 was assigned to the OH stretch in B-OH which is a 
formation of a product 𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝑂𝐻12]. On the other hand, the band around 2550 cm
-1  was 
attributed to the B-H stretch in 𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝐻12] and it decreased gradually during the reaction 
until it totally disappeared on day fifteen’s spectrum. 
      Figure 5-8 shows 11B NMR spectra of the cationic exchange chromatography process. The 
11B NMR spectrum of   𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝐻12] , 𝐶𝑠2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝑂𝐻12], 𝑎𝑛𝑑  𝑇𝐵𝐴2[𝑐𝑙𝑜𝑠𝑜 −
𝐵12𝐻12]were compared to approve the conversion of Cs with TBA. The starting material appears 
at -17.4 ppm while the product appears at – 20 ppm. When the Cs was replaced, the peak shifted 
downfield to -18.2 ppm. 
      The last step, etherification, was also monitored by 11B NMR spectra and FTIR. (Figure 
5-9& 10) display the 11B NMR and FTIR spectra of the reactants and product Br-
PBA, 𝑇𝐵𝐴2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝑂𝐻12], PBA closomer respectively. The NMR spectroscopy results 
proved the successful formation of the desired material. Moreover, FTIR results confirmed the 
formation of the final product. According to the FTIR spectra in (Figure 5-10), which is a 
comparison between the reactants and the product. The OH stretch band at 3250 cm-1 was assigned 
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to B-OH. By forming the final product, a stretching band around 3000 cm-1 was observed which 
corresponds to =C-H while a stretch around 1650  cm-1 corresponds to C=C. For C-O formation,  
bending and stretching vibrations were observed at 1000 and 1300 cm-1 respectively. Additionally, 
a B-O stretch was found to be around 1400 cm-1. 
5.6 Mechanism of cage hydroxylation reaction  
By looking at the reaction progression of the cage hydroxylation 11B NMR spectra (Figure 
5-6), we believe that the reaction proceeded by a sequential mechanism and are seeking to confirm 
that. Therefore, some theoretical calculations as well as time analysis study using 11B NMR 
spectroscopy have been done and qualitatively discussed.  
5.6.1 Experimental data   
In order to obtain as much of the data points and be able to study the real time Cs2B12H12 
hydroxylation mechanism, the reaction was performed in quartz NMR tube and kept in the magnet 
over long periods of time at 100 °C. NMR spectra were acquired every five minutes to monitor the 
reaction progression.   
5.6.2 Theoretical calculation  
Density functional theory (DFT) was utilized to simulate 11B NMR spectra of different 
models. B3LYP/6.31G(d,p) was used as a basis set of all calculations. Gaussian 03 was used to 
create the input files. All calculations were done using supercomputer Lewis cluster at MU.  
5.6.3 Comparison of experimental and theoretical results  
Allegedly, there are 12 different simulations but according to the script results shown 
below, it is more complicated than that. In an icosahedron structure, there are one, two, and three 
bond distance lengths that are possible to have as shown in (Figure 5-11).  The first column 
represents the total number of configurations. The rest of the columns represent the number of 
126 
 
different unique possibilities to have a replacement in zero, single, double and triple length bond 
distances respectively. For instance, if one hydrogen in the cage is replaced by hydroxyl group 
nOH=1, there are twelve positions that are possible for the replacement. All these positions are 
chemically equivalent, thus there will be twelve total number of configurations. When another 
hydroxyl group is attached to the cage nOH=2, there are different possibilities where it can be. 
One option could be that the hydroxyl group can be the first nearest neighbor. Another option 
would be that the hydroxyl group will be the second nearest neighbor, while the last option would 
be that the hydroxyl group will be the third nearest neighbor (Figure5-12). All these options lead 
to 66 total number of configurations.    
When three hydroxyl groups are attached to the cage nOH=3, multiple options would exist. 
There are 220 unique configurations. As shown in (Figure 5-13), each OH can be in each row (A), 
and there will be 60 versions of these configurations or 2 OHs can be in the first row and another 
one in second row (B) and there will be 60 versions and another 60 for the reverse situation(D). 
There will be 20 versions of having all OHs in first row(C) and another 20 when having OHs in 
the second row (E). Each row should be NMR equivalent. As the nOH increases, the unique 
configurations increase and reach 924 configurations when nOH=6.  
Therefore, it is important to clarify that the simulated data shown was not intended to be a 
one to one comparison because not all possible configurations were included in the presented data. 
There are 5020 configurations of possible intermediates with 1-11 OH substitutions. Hence, this 
study has approximately one or two models per type of configuration in order to qualitatively 
understand the reaction mechanism. Given the complexity of all these configurations, it would be 
unreasonable to accomplish all these calculations.  
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We hypothesized that the actual mechanism of replacing an H with an O-H is done 
sequentially. Therefore, the experimental results will be presented and supported by theoretical 
results. The results presented in (Figure 5-14) are the raw data of experimental NMR spectra while 
the results presented in (Figure 5-15) demonstrate the NMR spectra obtained from theoretical 
calculation. As shown in these figures, the experimental and theoretical results appear to follow 
the same trend in the reaction mechanism.  Both results started out with the same spectra for the 
starting materials, where only a single peak was observed. Then, both results trend in the same 
direction. In the experimental results, some peaks in the downfield region were going up and then 
down in the first few spectra, and that was relatively consistent with what was observed in the 
theoretical result. Likewise, the ending point in both the experimental and theoretical results were 
comparable. 
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nOH = 1, total number of configurations = 12 
NMR equivalent configuration’s = 
   12    1    0    0    0 
 
nOH = 2, total number of configurations = 66 
NMR equivalent configuration’s = 
   30    2    1    0    0 
   30    2    0    1    0 
    6     2    0    0    1 
 
nOH = 3, total number of configurations = 220 
NMR equivalent configuration’s = 
 
   60    3    1    1    1 
   60    3    2    1    0 
   20    3    3    0    0 
   60    3    1    2    0 
   20    3    0    3    0 
 
nOH = 4, total number of configurations = 495 
NMR equivalent configuration’s = 
 
    15     4     2     2     2 
   120    4     3     2     1 
   120    4     2     3     1 
    60     4     4     2     0 
    60     4     3     3     0 
    30     4     5     1     0 
    60     4     2     4     0 
    30     4     1     5     0 
 
nOH = 5, total number of configurations = 792 
NMR equivalent configuration’s = 
 
   120     5     4     4     2 
    60      5     6     3     1 
   180     5     4     5     1 
   180     5     5     4     1 
    60      5     3     6     1 
    60      5     7     3     0 
    72      5     5     5     0 
    60      5     3     7     0 
 
nOH = 6, total number of configurations = 924 
NMR equivalent configuration’s = 
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   180     6     7     6     2 
   180     6     6     7     2 
    20      6     6     6     3 
    60      6     9     5     1 
   120     6     8     6     1 
   120     6     6     8     1 
   120     6     7     7     1 
    60      6     5     9     1 
    12      6    10    5     0 
    20      6     9     6     0 
    20      6     6     9     0 
    12      6     5    10    0 
 
nOH = 7, total number of configurations = 792 
NMR equivalent configuration’s = 
 
   120     7     9     9      3 
   180     7    10     9     2 
    60      7     8    11     2 
   180     7     9    10     2 
    60      7    11     8     2 
    60      7    12     8     1 
    72      7    10    10    1 
    60      7     8    12     1 
 
nOH = 8, total number of configurations = 495 
NMR equivalent configuration’s = 
 
    15     8    12    12     4 
   120    8    13    12     3 
   120    8    12    13     3 
    60     8    13    13     2 
    60     8    14    12     2 
    60     8    12    14     2 
    30     8    15    11     2 
    30     8    11    15     2 
 
nOH = 9, total number of configurations = 220 
NMR equivalent configuration’s = 
 
   60    9   16   16    4 
   60    9   16   17    3 
   20    9   18   15    3 
   60    9   17   16    3 
   20    9   15   18    3 
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nOH = 10, total number of configurations = 66 
NMR equivalent configuration’s = 
 
   30   10   20   21    4 
   30   10   21   20    4 
    6    10   20   20    5 
 
nOH = 11, total number of configurations = 12 
NMR equivalent configuration’s = 
 
   12   11   25   25    5 
 
nOH = 12, total number of configurations = 1 
NMR equivalent configuration’s = 
 
    1   12   30   30    6  
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5.7 Conclusion and future work  
In conclusion, the PBA-closomer was successfully synthesized and the results were 
analyzed and confirmed using 11B NMR and FT-IR spectroscopy. Future research by our 
collaborators in the School of Pharmacy will perform biological testing including: basic HIV gp-
120 and PBA-closomer binding interaction, basic cytotoxicity testing, and CD4/gp120 binding 
prevention experiment.  
Moreover, since two HIV drugs have been studied, a dual drug will be formed, which will 
be a combination of PBA-closomer and maraviroc, and the drug release will be studied using 11B 
and 19F NMR spectroscopy.    
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Figure 5-1. Mechanism of HIV entry   
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 Figure 5-3. Cage hydroxylation    
Figure 5-2. The overall synthetic scheme 
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Figure 5-4. The cationic exchange chromatography 
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Figure 5-5. Cage etherification 
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Figure 5-6. 11B NMR spectra of day 0: starting material, day 2,7and 10: (intermediate) 
reaction progression, and day15: the product. 
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Figure 5-7. FT-IR spectra for the reaction progression 
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         Figure 5-8 . 11B NMR spectra of the stating materials and the product of the cationic 
exchange chromatography process 
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Figure 5-9. 11B NMR spectra confirming the step two etherification. 1: Br-PBA, 2: TBA2 B12OH12 , 
3: PBA-closomer. 
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Figure 5-10. FTIR for black: PBA-closomer, red: Br-PBA and blue: 𝑇𝐵𝐴2[𝑐𝑙𝑜𝑠𝑜 − 𝐵12𝑂𝐻12], 
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          Figure 5-11. Different internuclear in an icosahedron 0 (yellow), 1(red), 2(blue), and 
3(green) bond distances apart. 
 
Figure 5-12. Some different possible configurations when nOH=1 and 2 
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Figure 5-13. Experimental result of 11B NMR spectra over time  
 
  
 
Figure 5-14. Some different possible configurations when nOH=3 
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Figure 5-15. Simulated 11 B NMR for cage-nOH structures 
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Part II. APPLICATIONS OF SOLID-STATE NMR SPECTROSCOPY 
 
 
Overview  
Solid-state NMR has proven to be an applicable technique for spectroscopic studies by 
expanding its uses in many fields such as chemistry, physics, biology, and geology. In part II of 
this dissertation, some applications of solid-state NMR spectroscopy will be presented and 
discussed in diverse research projects.  
      In chapter 7, the local physical structure of different boron carbide thin films were 
examined via solid-state NMR spectroscopy. A number of SSNMR experiments and results were 
discussed.  
 In chapter 8, SSNMR spectroscopy technique was utilized to study TiO2, and improve its 
optical properties. 
Objectives  
     The overall objectives of this part of the dissertation are: 
1. Apply SSNMR spectroscopy techniques to study the internal structure of  boron carbide 
thin films grown by plasma enhanced chemical vapor deposition (PECVD)   
2. Monitor the progress of TiO2 reaction, and study green and white TiO2 using SSNMR 
spectroscopy.  
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6.1 The concept of magic-angle spinning (MAS) 
Typically, a SSNMR spectrum is broader and has a lower resolution compared to the 
solution NMR spectrum. There are three important contributions that make the SSNMR spectrum 
somewhat featureless. First is the dipolar broadening which is the dipolar interaction between two 
spins. This interaction can be either a homonuclear or heteronuclear interactions. Equations 6-1&2 
show the Hamiltonian of homonuclear and heteronuclear interactions respectively. The second 
reason is the chemical shift anisotropy (CSA), which arises from the asymmetry of electronic 
density around the nuclei and the Hamiltonian of CSA is given in Equation (6-3). The last 
contribution is the first-order quadrupolar interaction. Equation (6-4) shows the basic form of the 
quadrupole Hamiltonian, which describes the interaction between the nuclear electric quadrupole 
moment eQ and electric field gradient EFG.  
The magnitudes of the second-order interaction of the dipolar and chemical shift anisotropy 
interaction are neglected compared to the Zeeman interaction. Nevertheless, the second-order 
quadrupolar interaction may have a sufficient magnitude that it cannot be neglected.  
 In the solution NMR spectroscopy, all these factors average to zero due to the rapid motion 
of the sample. However, in SSNMR this assumption is no longer accurate. Fortunately, we can 
average most of these factors to zero and acquire high-resolution spectra with narrow lines using 
a technique called magic angle spinning (MAS) since all of the factors are orientation dependent 
with a similar orientation dependence [ D(ɵ) α 3cos2 (ɵ)-1 ] (Figure 6-1). This can be achieved 
through the mechanical rotation of the sample at 54.74° with respect to the magnetic field in 
151 
 
addition to the rapid sample rotation. The dipolar interaction and first-order quadrupolar 
interactions will be restored individually by applying pulses to the spin state, which will change 
the product to a non-zero value as shown in (Figure 6-2).  
                                                                                  
                                                                                                                               
                                                                
            
 
 
 
 
      
          ĤQ =
𝑒𝑄
2𝐼(2𝐼−1)ħ
Î. 𝑉. Î 
 
Where: Q is the nuclear quadrupole moment 
               I is for spin I 
                Î is the nuclear spin vector  
6.2 Magic-angle spinning setup 
  Since the discovery of magic angle spinning in SSNMR, the applications of this method 
have significantly increased in numerous fields such as chemistry, biology and pharmacy 1.  The 
sample should be packed in a rotor and placed in the angle 54.74o with respect to the applied 
magnetic field. Additionally, the magic angle spinning rate must be equal to or higher than the 
magnitude of the anisotropic interaction to average it to zero. Setting this angle on 54.74o 
(6-1) 
(6-2) 
(6-3) 
(6-4) 
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accurately is essential before doing 90 calibration or SSNMR experiments since it has a deleterious 
effect on different NMR parameters namely: 1) line-width, 2) line-position, and 3) signal to noise 
ratio S/N.   
 Different methods have been suggested to place the sample on the magic angle 2–4. 
However, an accurate and simple way to accomplish this degree of angle is by using potassium 
bromide (KBr)5.  79Br is utilized since the crystal structure of KBr is a cubic and bromine is a small 
1st order quadrupole, but large enough to exhibit averaging by MAS. Additionally, the 79Br 
resonance frequency is very close to that of 13C, so little effort is needed to tune the probe back. 
Most new MAS SSNMR probes have an adjustable knob to manipulate the tuning mechanically. 
During this method, the 79Br signal is going to be monitored to obtain the maximum number of 
rotational echoes with the largest amplitude.    
6.3 Quadrupole nuclei in SSNMR spectroscopy  
 Typically, SSNMR studies apply to 1H and 13C nuclei, which have a spin I=1/2. However, 
by looking at the periodic table, 74% of active NMR isotopes are quadrupolar nuclei meaning that 
100 of 130 magnetically active naturally occurring isotopes are quadrupolar nuclei (spine I > 
½)(Figure 6-3)6. In SSNMR, quadrupole nuclei are in fact essential. On the other hand, they are 
quadrupolar nuclei, thus, there will be an electric quadrupolar interaction, which is responsible for 
broadening the SSNMR signal.  Consequently, acquiring and interpreting the SSNMR spectra of 
these nuclei leads to some difficulties. However, studying them provides a lot of information, 
particularly in inorganic chemistry and materials applications. Therefore, the high demand of 
inorganic characterization for different materials led to a significant improvement in the 
quadrupolar nuclei SSNMR experimental techniques. In 1998, more than 400 references in 
SSNMR studies of quadrupolar nuclei demonstrated that the electric quadrupolar interaction 
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problem can be overcome and invaluable information can be acquired from SSNMR 
spectroscopy7.  
6.4 Quadrupolar relaxation 
      This type of relaxation applies only for nuclei with a spin I >1/2, where the positive charge 
distribution has the shape of an oblate or prolate spheroid.  Moreover, in these quadrupolar nuclei, 
the electric field gradient (EFG) exerts a torque, and molecular tumbling can initiate transitions 
among the spin states. Quadrupolar relaxation critically depends on a quadrupole moment (Q), 
which is 0 for spin=1/2 nuclei. When the quadrupole moment is small (such as 2H and 6Li with 
spin I=1), the nuclei behaves similarly to a nuclei with spin I=1/2. Hence, a sharp NMR peak will 
be observed. However, when the quadrupole moment is large, the nucleus will have a very short 
T1 Equation (6-5). Thus, the observation of NMR signals and spin-spin splitting to the nucleus 
will be hindered.   
      In some molecules with tetrahedral or octahedral symmetry, the electric field gradient is 
small or zero, which will allow T1 to be long enough to acquire an acceptable NMR spectra. When 
the quadrupole moment (Q) is large, it will show a very fast quadrupole relaxation whether there 
is a properly symmetric environment or not.  
      Quadrupole relaxation not only affects the nuclei itself, but it is also affects the neighboring 
active nuclei. This can happen because of a very rapid quadrupole relaxation resulting in 
broadening or completely removing the J-coupling between two nuclei. 11B-X group is a very 
common example for this effect. In a boron NMR experiment, a T2 effect on the X nucleus, which 
is the interchange of spin states, is the main reason of broadening the boron spectra. Hence, it will 
make observing the connection between boron directly bonded to carbon or proton almost 
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unmanageable. Boron nuclei can be classified as a self-decoupled nuclei as it has a very fast 
quadrupole relaxation that will suppress all coupling with the nearby carbon or proton.  
 
        𝑅𝑄𝑅 =
1
𝑇1(𝑄𝑅)
=
3
10
𝛱2
2𝐼+3
𝐼2(2𝐼−1)
(1 +
Ƞ2
3
)(
𝑒2𝑄𝑞𝑧
ℎ
)2𝜏𝑐                      (6-5) 
Where: 
Ƞ = the asymmetry of electric field  
Q= quadrupole moment of nuclei 
q= electric field gradient  
I= nuclear spin 
τ= molecular correlation time  
6.5 Basic SSNMR experiments: 
  Prior to any SSNMR experiment, there are several parameters which have to be set up 
precisely in each channel in the NMR probe in order to get a spectrum with better resolution and 
a narrow line8. An initial parameter is shimming. The magnet has to be shimmed properly to make 
sure that the magnetic field around the sample is homogenous. This step should be performed 
infrequently unless a substantial change occurs to the probe.  
  In contrast to the shimming, the NMR probe has to be tuned more frequently to a desired 
frequency to maximize the power carried to the sample so an optimal signal to noise ratio can be 
achieved.   
      The RF pulse calibration is the most important parameter which has a critical effect on the 
collected NMR spectra. The purpose of the pulse calibration is to determine the pulse width 
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required to produce to a 90 degree pulse. This experiment can be achieved by obtaining a series of 
NMR spectra while increasing the RF pulse widths incrementally.  After Fourier transforming the 
spectra, the calibration curve, known as nutation curve, can be plotted which includes the NMR 
signals as a function of the RF pulse widths. As shown in (Figure 6-4), while increasing a pulse 
width, the height of the peak increases as a sin function. The first maximum represents the 90 
degree pulse width while the first zero-crossing represents the 180 degree pulse width 9.     
T1 measurement and estimation is equally as important as other NMR parameters. It 
provides the relaxation time, which is related to the repetition time of an experiment. The most 
common experiment to obtain T1 value is called an inversion recovery experiment. It measures 
the time it takes for the magnetization to convert back from –Iz to +Iz. Figure 6-5 shows the pulse 
sequence as it has a 180o inversion pulse, tau time (τ), and then a 90 o pulse. As shown in (Figure 
6-5), the tau time (τ) increases gradually in each experiment, and the signal intensity can be plotted 
as a function of tau. The data could be fitted as a non-linear regression fit Equation (6-6) 10.  
                 I(τ) = I∞(1-2exp(-τ/T1))                                                (6-6) 
   Once all the SSNMR parameters are set up accurately, several SSNMR experiments can 
be performed to obtain fundamental information about different nuclei. 
6.5.1 Direct excitation   
The direct excitation experiment is a quantitative experiment, which has a quick and simple 
way to elucidate information about the chemical shift for any active nuclei in the sample.  
Typically, it is the first experiment performed since it can demonstrate the chemical identity. The 
pulse sequence of the direct excitation experiment with heteronuclear contentious wave 1H 
decoupling is shown in (Figure 6-6)11.  Generally, this experiment is applied for each nucleus in 
every single project.  
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6.5.2 Cross Polarization experiment   
Cross polarization experiment (CP) can be classified as a starting point for deep and 
complex analysis in SSNMR spectroscopy. It has been applied successfully to define the 
structure of several molecules11–15.  Commonly, the CP experiment is acquired with a 
combination of magic angle spinning (MAS) as well as heteronuclear dipolar decoupling. The 
magic angle spinning and the heteronuclear dipolar decoupling serve as tools to improve the 
resolution of the spectra while the cross polarization assists to increase the experiment 
sensitivity. 
The principle behind this experiment is that the signal of low gamma nuclei will be 
enhanced by a transfer of polarization from a high gamma nucleus such as 1H, to less abundant 
nuclei such as 13C, via heteronuclear dipolar coupling. In order to transfer the polarization, the 
Hartmann-Hahn condition must be fulfilled Equation (6-7)  
ℽI BI = ℽS BS                         (6-7) 
Where: ℽ is the gyromagnetic ratio  
             B is the amplitude of radio frequency (r.f) applied to each nuclei 
The magnetization transformation can be visualized in terms of energy levels as shown in 
(Figure 6-7). Once the Hartmann-Hahn condition is satisfied, the polarization equalizes between 
the nuclei leading to an enhanced polarization in the low gamma species (Figure 6-8)16. The pulse 
sequence of the CP experiment is shown in (Figure 6-9), where an application of the pulse to both 
nuclei occurs simultaneously. By obtaining CP spectra, we can have a hint about which nuclei are 
close enough to protons to see the transfer. 
Lee-Goldburg (LG) cross polarization is another version of CP experiment. In LG-CP 
experiment, 1H-1H homonuclear dipolar interaction will be suppressed, and X-1H pin-pair 
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interaction in isolation will be permitted in order to get more precise information about the dipolar 
coupling strength. This can happen by irradiating the proton spin with a LG homonuclear 
decoupling pulse. Figure 6-10 shows the pulse sequence of the LG-CP experiment.   
 By quantifying the LG-CP oscillations and build-up curves, an estimation of dipolar 
coupling can be made which ultimately will lead to structural information. Additionally, the 
distances between 1H and other nuclei can be elucidated, allowing a conception of whether the 
distance is short, medium, or long between these nuclei as shown in (Figure 6-11). This 
information about distances will be very helpful for building an image for the internal structure. 
For example, if the distance between the two nuclei is short, that means the X nucleus is directly 
bound to the proton and a fast oscillation will be detected in the build-up curve. When the distance 
is long, that indicates the X nucleus does not have a proton and the nearest proton is far away. 
Therefore, a slow oscillation in the build-up curve will be identified5,17–22. 
6.5.3 Rotational-echo adiabatic passage double resonance (REAPDOR)   
The Rotational-echo adiabatic-passage double-resonance experiment is an expansion of 
Rotational-echo double-resonance (REDOR). It is well-documented tool which is designed to 
selectivity reintroduce the dipolar interaction between spin I=1/2 and spin S>1/2. Recovery of the 
heteronuclear dipole interaction between these two spins may be used to accurately measure the 
intera-nuclear distance since the dipolar interaction depends on the inverse cube of the distance 
between two nuclei. The REAPDOR experiment has been applied successfully to measure the 
distance between 13C -11B23.  In order to obtain a REAPDOR curve, two experiments must be 
acquired as shown in (Figure 6-12), and the spinning rate has to be precise. One experiment is 
obtained with a middle pulse in the 11B channel to recouple the heteronuclear interaction and 
measure the dephasing in 11B signal S. Another experiment is also obtained with an elimination of 
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the middle pulse in 11B channel which will produce a reference signal S0. The result is expressed 
according to Equation (6-8) which is a plot of that equation versus dipole evolution time. By fitting 
these data to a theoretical curve, information about the inter-molecular distance can be achieved.  
∆S/S0 = (S0 - S)/S0               (6-8) 
6.5.4 2D Homonuclear correlation experiment 
  The objective of this experiment is to reintroduce the homonuclear coupling and identify 
the correlation between two identical nuclei such as 13C -13C. There are a variety of experiments, 
which can be done to achieve this goal such as Dipolar Rrecoupling Using A Windowless 
Sequence (DRAWS), finite pulse Radio-frequency-driven recoupling (fpRFDR), and SPC24–26. 
The 2- dimensional NMR spectrum is presented as a plot of intensity versus two frequencies as 
shown in (Figure 6-13)8. A precise interpretation of 2D spectrum can reveal useful information 
about the correlations between different nuclei in different environments. In 2D spectrum, cross 
peaks represent a correlation between two nuclei. 
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Figure 6-1.  Placing the sample in the magic angle (3cos
2
 Ɵ - 1 = 0 when Ɵ = 54.74°) 
Figure 6-2.  Recoupling the dipolar interaction and first-order quadrupolar interactions under 
MAS by applying pulses to the spin state to change the product to a non-zero value 
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Figure 6-3. Periodic table showing that 74% of active NMR isotopes are quadrupolar nuclei 
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Figure 6-4. Nutation curve for the RF pulse calibration 
Figure 6-5. Inversion recovery experiment to measure T1 
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          X 
Figure 6-6. Pulse sequence of direct excitation 
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Figure 6-7. Magnetization transformation as energy level   
Figure 6-8. The polarization transfer 
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Figure 6-9. Cross polarization pulse sequence 
Figure 6-10.pulse sequence of the LG-CP experiment 
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Figure 6-11. REAPDOR experiment pulse sequence 
 
 
               Figure 6-12. 2-D LG-CP build-up curves of tyrosine‚HCl 
Fast build up, and fast oscillation indicates short distance to nearest neighboring protons 
Slow build up with slow or no oscillation indicates long distance 
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Figure 6-13. 2D NMR spectrum indicating possible correlations 
between peaks in ethanol 
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   7.1 Introduction  
Boron carbides (BC) are a class of icosahedral boron-rich molecular solids. They are 
known as one of the hardest materials at room temperature. Moreover, they are chemically inert, 
and very thermostable. Although boron has three valence electrons, it has the tendency to form 
unusual three-center two-electron bonds and is inclined to organize itself in stable deltahedra 
(Figure 7-1). On account of their unique thermal, mechanical, and electrical properties, boron rich 
carbides have many applications including, protective armor due to its light weight and neutron 
detectors because of the high cross section for the absorption of neutrons (10B). Boron rich carbides 
may be formulated as low-k dielectric materials, which can be utilized for ultra large scale 
integrated circuit design. Additionally, they are used as p-type semiconductors in the 
semiconductor devices1–5.  
The local physical structure of boron carbide has been the subject of many studies2,6. The 
lattice structure of crystalline boron carbide has twelve icosahedra at the vertices of a 
rhombohedral unit cell (Figure 7-2). There are six atoms in each icosahedron at polar sites and 
they are bound directly to neighboring icosahedra. Furthermore, six equatorial atoms are bound to 
the three-atom chain, which is located on the crystallographic c axis. The stoichiometry of 
crystalline boron carbide can range from B4.3C to B11.2C without undergoing a phase change. It is 
known that at the carbon-rich limit (B4.3C) is composed mostly of B11C icosahedra and C-B-C 
chains. As the relative boron content increases and the solid becomes more boron rich, B atoms 
are replaced with C atoms, one by one. Amorphous hydrogenated boron carbide has a similar 
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icosahedral building block; however, the physical structure is essentially different. The reason for 
this difference is the lack of long-range order along with the attachment of hydrogen7.  
Many studies have been done to discover the local structure of boron rich carbide8,9. 
However, these studies do not give conclusive evidence for the structure of the thin film. 
Diffraction techniques (X-ray, neutron, electron) are methods used to identify the atomic and 
molecular structure of crystal10.  Pair distribution functions use the distribution of bond lengths 
and interatomic distances to illustrate structural information. However, this study works with 
boron and carbon, which are known as low Z materials and low X-ray atomic scattering factors. 
Thus, the intensity is too weak, and it is hard to acquire any structural information from these 
techniques. The electron atomic scattering factors for B and C are much larger than X-ray atomic 
scattering factors by a factor of ∼108. Accordingly, it is accessible to identify the structure of thin 
films. On the other hand, the resolution is low due to the complex and amorphous structure. The 
neutron scattering of B and C are not distinguishable from each other since they have very close 
neutron scattering lengths. In addition, the neutron source is too expensive and that bounds the 
operation of this technique. 
  X-ray photoemission spectroscopy (XPS), also known as electron spectroscopy for 
chemical analysis (ESCA), is another tool that can aid in identifying the local structure of boron 
carbide thin films. XPS is a surface-sensitive quantitative spectroscopic technique that has been 
widely used to analyze the surface chemistry of boron carbide thin film11,12. XPS can probe the 
empirical formula, chemical state, electronic state of elements that are present in these materials.  
The average depth of analysis for an XPS measurement is approximately (0-10nm). Hence, only 
the elements on the surface will be recognized. If the surface is different from what is below, the 
determination of the inner structure would be missing. A depth profile experiment can be 
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performed, but the deeper we go the more energy goes into the sample, which would cause a 
change or damage the structure. Moreover, XPS does not easily detect elements with a low atomic 
number (Z) like hydrogen (Z=1) or Helium (Z=2), and it is more challenging to detect B and C in 
which the signal to noise ratio is weaker than heavier atoms. Under these circumstances, we might 
overestimate the ratio between the elements. Therefore, these weaknesses of XPS spectroscopy 
restrict a consistent use of XPS in the characterization of boron carbide thin films structure. 
Near Edge X-Ray Absorption Fine Structure (NEXAFS) spectroscopy is an element 
specific method. It usually measures the light elements like carbon, oxygen, and nitrogen, and it is 
essentially equivalent to X-Ray Absorption Near Edge Structure (XANES) spectroscopy. These 
techniques can be helpful in probing the local physical structure of boron carbide by determining 
the local bonding and the oxidation state of the elements13,14.  Continued scanning leads into what 
is called Extended X-ray Absorption Fine Structure (EXAFS) spectroscopy. This contains 
information about interactions with the nearest neighbor atom as well as bond order. Although 
these techniques can illuminate structural clues to the overall physical structure of boron carbide 
thin films, the spectra are difficult to interpret. 
Electron microprobe analysis (EMPA), also named electron probe microanalysis (EPMA), 
is a non-destructive analytical method to characterize the chemical composition of a few mm in 
the substantial size. EPMA has been used for defining the electronic structure of graphite15 . EPMA 
not only identifies the electronic structure but also provides valuable information about bonds in 
carbon and boron materials. EMPA falls short because it cannot detect Hydrogen, so we cannot 
count on this technique to characterize the local physical structure of boron carbide. 
Fourier transform infrared spectroscopy (FT-IR) has been a workhorse tool for qualitative 
and quantitative examination of the local physical structure of boron carbide thin films. FT-IR can 
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measure the absorption or emission of a liquid, solid, or gas. The critical information that can be 
acquired from FT-IR spectroscopy is bond types and functional groups of boron carbide thin films 
through the analysis of local vibrational modes. Even though FT-IR has revealed relatively 
insightful information about the local physical structure of boron carbide thin films, key 
information is still unknown, such as the position of these bonds and the connectivity between the 
elements. Additionally, sometimes it is hard to interpret FT-IR data. For these reasons, other 
techniques must be used in conjugation with FT-IR spectroscopy to fully characterize the local 
physical structure of boron carbide thin films16–18. 
In contrast to other spectroscopic methods, NMR does not require long-range constitutional 
order. It can efficaciously study the short-range chemical and physical structure as well as the 
intermediate–range connectivity. The spectrum can be interpreted entirely. It can expose the 
structure and chemical environment of molecules, as well as reaction dynamics, and reaction 
states. Additionally, NMR extends further than all possible techniques by obtaining 2D 
experiments, which allows the flexibility to manipulate the spectrum and isolate different atoms.  
7.2 General Research Approach 
  The current study investigates the local physical structure of boron carbide thin-films. Even 
when using the same material precursor (ortho-carborane and labeled methane), the properties of 
hydrogenated boron carbide thin films vary considerably under different experimental conditions. 
With various properties, each of these thin films can be suitable for different types of 
semiconductor devices. Considering the fact that an identical precursor can lead to thin films with 
distinct properties clearly means that there are local, molecular structural differences between 
these. Hence, this study investigates the local structure of boron carbide thin films, which will help 
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to correlate the structure and properties of thin film. Understanding this relationship will help to 
discover the best conditions for making more efficient semi-conductor devices.  
Plasma enhanced chemical vapor deposition (PECVD) was utilized to grow different 
materials under different growth conditions. Solid-state NMR spectroscopy techniques were 
applied to characterize the local physical structure of thin films. 
7.3 Film growth and sample preparation 
Plasma enhanced chemical vapor deposition (PECVD) was used to grow boron-carbide 
thin films (Figure 7-3)18. In this process,13C-labeled methane and ortho-carborane were sublimed. 
The 13C-labeled methane and ortho-carborane gases were delivered to the reactor using Ar gas as 
a carrier gas. With the starting materials and Ar gasses present in the plasma, the chemical reaction 
took place. Fragments are deposited on Al substrate19.  
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7.4 SSNMR experiments 
  All the SSNMR spectroscopy was carried out on a three channel Tecmag Apollo console 
with 8.45 T magnet and homebuilt double- and triple-resonance SSNMR probes. For 11B, 13C 
spectra, 3.2 mm probe was used with MAS frequency 10 KHz to obtain the best resolution. The 
frequency of detecting nuclei, namely 1H, 11B, and 13C are 357.200 MHz, 114.602 MHz, and 
89.821MHz respectively. With three active nuclei, there are quite a few SSNMR experiments that 
can illustrate the local physical structure of boron carbide thin films as they were discussed in 
detail in previous chapter.   
7.5 Results and discussion  
7.5.1 Film growth and sample preparation 
Table 7-1 shows the growth condition of the interest materials. Thin films of 13C-labeled 
methane and ortho-carborane grew successfully with a thickness up to 2-3 um. The thin-films were 
isolated from Al substrate by dissolving the substrate in dilute HCl 19. The treatment of thin films 
with HCl may influence the physical or chemical structure of thin films, but insignificant changes 
in IR spectra were detected before and after the treatment with HCl. By using dilute HCl, a 
sufficient amount of isolated materials can be obtained at a low cost. In order to prepare the 
samples for SSNMR studies, the isolated materials were crushed gently and packed in the rotors 
at a weight of approximately 2mg per sample in each rotor.  
7.5.2 Direct excitation experiment 
  Figure 7-4 shows the 11B NMR spectra of three different thin films namely: M13C3, 
M13C4, and M13C5. According to the spectra, no shift in 11B peak has been observed. Therefore, 
the 11B in all of these samples have the same chemical environment.  
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7.5.3 Lee-Goldburg Cross Polarization experiment (LGCP) 
The LGCP experiment provides information about the strength of the interaction between 
13C-1H. Figure 7-5 illustrates the result of LG-CP experiment for the reference U-13C Alanine. By 
looking at the shape of each buildup curve and the time scale, we clearly can notice a different 
strength of interaction between 13C and 1H. In the alpha carbon, the oscillation was very fast and 
the buildup curve time was rapid which confirms that proton and carbon are adjacent. For the 
methyl group, the oscillation and the buildup curve was not as fast as alpha and that approves a 
small distance between carbon and proton. Carbonyl, on the other hand, has a slower oscillation 
and longer buildup curve time, which indicates that carbonyl has a proton but not that nearby. All 
our samples behave similarly in LG-CP experiment. Figures (7-6 A, B, and C) show the result of 
LG-CP experiment for all thin films.  When examining across the peak from left to right, the 
interactions are clearly changing. There is a different oscillation and buildup curve time in each 
side of the peak for each sample. Therefore, we have slightly different chemical environment 
across the peak.  
7.5.4 Rotational-echo adiabatic passage double resonance (REAPDOR)   
The results of REAPDOR experiments are shown in (Figures 7-7 A, B, and C). The spectra 
were acquired at a different time scale.  The blue spectra S is the dephased, while the red spectra 
is the control So). Since there was no difference detected between S and So signals, there are not 
boron bound to the carbon. Approximately all the samples have the same carbon and boron 
distribution. 
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7.5.5 2D-SPC Homonuclear correlation experiment 
 Figure 7-8 illustrates the correlation in the control sample UALA. However, the samples 
M13C4, 5 revealed no correlation since no off diagonal pieces have been observed (Figure 7-9 A 
and B). The result obtained was not unexpected since only part of the sample was labeled.  
7.6 conclusion and future work 
In conclusion, we have moderately collected some information about the 13C labeled 
methane and ortho- carborane thin films grown by PECVD. Our analysis was hampered by a low 
signal-to-noise ratio due to the low natural abundance of 13C, and the useful information that we 
could obtain from SSNMR spectroscopy about the local physical structure of ortho-carborane thin 
film was dramatically reduced. 
  Consequently, for the future work, we are planning to isotopically enrich the precursor 
ortho-carborane with 13C carbons. Using13C labeled ortho-carborane would have major outcomes: 
improvement in S/N by a factor of ~90 fold in 13C experiment, and the ability to measure 
interatomic distances by doing carbon-carbon correlation experiments and 2D experiments. We 
have started synthesizing ortho-carborane as shown in the synthetic scheme in Appendix I.  
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Figure 7-1. The icosahedral building block of boron-rich solids, with contours illustrating bonding 
electron density. 
 
Figure 7-2. Boron carbide crystal structure 
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Figure 7-3. Plasma enhanced chemical vapor deposition PECVD growth of thin film 
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Name Power  Temperatur
e 
Pressure  Ar+ortho Methane 
13C 
Growth 
time 
M13C_3 40W 275C 2 Torr 190sccm* 10 sccm 30 min 
M13C_4 40W 275C 2 Torr 150sccm*  50 sccm 30 min 
M13C_5 40W 275C 2 Torr 175sccm* 25 sccm 30 min 
        Table 7-1. Growth condition of thin films using PECVD 
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                           Figure 7-4. 11B NMR spectra, direct excitation experiment 
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                                Figure 7-5. LG-CP result for reference U-13C Alanine 
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Figure 7-6. LG-CP results for all thin films A: M13C3, B: M13C4, and C: M13C5 
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                               REAPDOR results for all thin film A: M13C3 
 
                                    REAPDOR results for all thin films B: M13C4 
 
185 
 
 
                                                                                                                                                                                                                      
 
 
 
 
 
 
       Figure 7-7. REAPDOR results for all thin films A: M13C3, B: M13C4, and C: M13C5 
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                         Figure 7-8. 2D-SPC result for UALA control to demonstrate pulse sequence is correct   
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Figure 7-9. 2D-SPC results thin films A: M13C4, and B: M13C5 
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8.1 Introduction 
Titanium oxide plays a significant role as a photocatalyst due to its distinctive 
photocatalytic activity. However, the band gap of TiO2 is actually wide, about 3.0-3.2 ev, and 
absorbs only the ultra-violet UV light, which represents a small portion of the natural sun light 
spectra1. Recently, enormous efforts have been made in order to improve the properties of TiO2 
and shift the absorption from UV region to visible light or infrared light regions. Such attempts 
have included doping the TiO2 with metal/nonmetal elements and coupling TiO2 with different 
colorful semiconductors or molecules. Some of those efforts have successfully tuned the properties 
of TiO2. In this project, the optical properties of green TiO2 were improved in a different way by 
introducing a hydrazine molecule, which is a bidendate ligand containing nitrogen atoms2,3. 
8.2 General research approach 
Different spectroscopic techniques have been used in this project to determine what 
differentiates the green and white TiO2 such as XPS, FT-IR and SSNMR. Green and white TiO2 
were prepared in the presence and absence of hydrazine monohydrochloride4.  
Our contribution to this project was applying SSNMR spectroscopy method, as it was a 
useful tool to reveal essential information about the reaction progression to synthesize a green and 
white TiO2 and structural determination of green and white TiO2
5. 
8.3 SSNMR experiment 
The SSNMR spectra was carried out on a three channel Tecmag Apollo console with 8.45 
T magnet and homebuilt double- and triple-resonance SSNMR probes. The frequency of 1H is 
357.200 MHz, and the magic angle frequency rate was 8 KHz. Adamantine was used as an external 
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reference. The proton direct excitation experiment was performed and each spectrum was acquired 
with 256 scans. Additionally, a proton spectrum was acquired for the empty rotor to measure the 
contribution of the rotor in the spectra. This contribution was then subtracted from each sample 
and the results were scaled by mass to obtain an accurate quantitative information about each 
sample.  
8.4 Results and discussion  
 Figure 8-1 shows the solid-state 1H NMR spectra of pure TiO2, pure hydrazine 
monohydrochloride, white TiO2, and green TiO2 respectively. Figure 8-2 closely demonstrates the 
difference between green and white TiO2. In both samples, green and white, there is a large broad 
peak around 5.43 ppm. Moreover, there is a peak near 1.11 ppm, which represents the absorption 
of H2O, and a peak around 0.00 ppm which represents the absorption of DMF solvent on the 
surface.  
 In green TiO2, a strong sharp peak was observed near 2.80 ppm and it is slightly different 
than the peak that was observed for hydrazine monohydrochloride around 3.08ppm (Figure 8-1). 
The slight difference indicates that the N in hydrazine was successfully substituted to the surface 
of TiO2.  
8.5 Conclusion  
Solid-state NMR spectroscopy has displayed a critical role in this project as it noticeably 
supported the completion of the formation of desired materials. Furthermore, it confirmed the 
coordination of the hydrazine molecule to the surface of titanium atoms Ti.  
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Figure 8-1. Solid-state NMR spectra for all samples 
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Figure 8-2. Solid-state NMR spectra for green and white TiO2 
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Appendix I 
Synthesis of 13C labeled ortho-carborane 
In order to improve the S/N and measure the interatomic distances, a 13C labeled precursor 
need to be synthesized. Since 13C labeled chemicals are very expensive, the first aim is to find a 
synthetic scheme that uses the least expensive starting materials.  Synthesizing ortho-carborane by 
reacting acetylene gas with decaborane has been done 1, but the yield was insufficient. Therefore, 
the studies were commenced by performing a proof of concept synthesis of ortho-carborane 
(before purchasing the rather expensive 13C propargyl alcohol) following these steps: first 
oxidizing propargyl alcohol to obtain propiolic acid2 , then protecting that with a t-butyl group to 
form t-butyl propiolate2 and finally ortho-carborane was synthesized from a reaction of t-butyl 
propiolate with decaborane3.  Solution NMR spectroscopy was used to analyze the results along 
with GCMS. 
      Currently, commercially available 13C labeled propargyl alcohol is used. Due to its high 
cost, future work will include an additional reaction before this proposed scheme. This new step 
will produce 13C labeled propargyl alcohol from 13C labeled acetylene4 as shown in (Figure 1) 
Preliminary Data 
Synthesis of propiolic acid 
Procedure: 
• Solution of propargyl alcohol was titrated with Jones reagent. The reaction mixture was 
stirred for an additional 1h at room temperature. 1ml of isopropanol was added to quench 
the Jones reagent. 100 ml of water was added, and the product was extracted with ethyl 
acetate. Figure 3 shows the 13C NMR spectrum of propiolic acid. 
•  Result:  
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• Yield of propiolic acid  was ⁓ 80% based on NMR spectrum integration (Figure 2). 
Synthesis of t-butyl propiolate 
• Procedure: 
A solution of propiolic acid and Et2O was cooled to -78 °c. (Reacting component 1).10 ml 
of isobutylene was condensed. (Reacting component 2). Reaction component 1 was added to 
reaction component 2, followed by 1 drop of H2SO4. Reaction mixture was held at -78 for 4h, 
then allowed to warm at rt overnight. The mixture was diluted with water and the aqueous 
layer separated and extracted 3 times with Et2O. Figure 4 a and b show the GCMS directly 
after synthesis and the final result respectively 
• Result:  
The yield of t-butyl propiolate was ⁓ 80% based on NMR spectrum integration (Figure3). 
Synthesis of ortho-carborane 
  This reaction is extremely water sensitive. All precautionary measures must be taken to 
completely eliminate water from the system. If these measures fail, boric acid will form instead of 
ortho- carborane. 
• Procedure: 
0.1g of decaborane was heated in acetonitrile (4 ml) to reflux under exclusion of oxygen and 
moisture. After 30 min, a solution of TBP (0.11ml) in anhydrous toluene (4ml) was added and the 
resulting mixture was heated. NMR spectra were acquired every 4 hours. After 15 hours, 1ml of 
methanol was added to the reaction mixture and refluxed for 30 min. Figure 4 shows the 11B NMR 
spectra during reaction. 
• Purification 
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  The reaction mixture was purified by column chromatography (hexane: ethyl acetate 10:1). 
Fractions were combined and concentrated. NMR was taken as shown in (Figure 5). 
• Result:  
Sublimation Recovery: ⁓ 95%. Yield of O- carborane ⁓ 40% (Figure 6) based on NMR 
integration.  
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Figure1. Proposed Scheme of synthesizing 13C ortho-carborane  
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Figure 2. 13C NMR spectrum of crude product 
Figure 3.a: GCMS of crude product, b: GCMS result of purified product 
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Figure 5. Fractions’ NMR spectra during purification process 
 
Figure 4. NMR spectra during reaction. The stars show one of the decaborane peaks 
disappearing as the reaction progresses. It is being converted to ortho-carborane.  
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Figure 6. Sublimation results. The top spectrum contains purified product. The bottom spectrum is 
the leftover from the sublimation process. The absence of peaks shows that the entire product 
sublimed. 
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